Nanotechnology in Rapid Viral Diagnostic Tests

Overview and Principles of Nanotechnology in Rapid Viral Diagnostic Tests

The Paradigm Shift in Veterinary Viral Diagnostics

The emergence and re-emergence of viral pathogens across domestic animal, aquatic, and wildlife populations have exposed critical vulnerabilities in traditional diagnostic paradigms. Conventional methods for viral detection, including virus isolation, serological assays, and nucleic acid amplification tests (NAATs) such as reverse-transcription quantitative polymerase chain reaction (RT-qPCR), remain the gold standards for sensitivity and specificity. However, these techniques are often tethered to centralized laboratory infrastructure, require highly trained personnel, involve protracted turnaround times extending to hours or days, and exhibit prohibitive costs that preclude their deployment in resource-limited settings [12, 18, 23]. The exigencies of outbreaks-such as those caused by highly contagious pathogens like Avian Influenza Virus, African Swine Fever Virus, and White Spot Syndrome Virus-demand diagnostic solutions that are not only accurate but also rapid, portable, and operationally simple. Nanotechnology has emerged as a transformative force in this context, offering a suite of materials and engineering principles that fundamentally re-engineer the sensitivity, speed, and format of viral detection [10, 12, 26].

The core principle underpinning nanotechnology-based rapid diagnostic tests (RDTs) is the exploitation of the unique physicochemical properties that emerge at the nanoscale (typically 1-100 nm). At this scale, materials exhibit markedly different optical, electronic, magnetic, and catalytic behaviors compared to their bulk counterparts. These properties are not merely incremental improvements; they enable entirely new transduction mechanisms for biorecognition events. For instance, the localized surface plasmon resonance (LSPR) of gold nanoparticles (AuNPs) allows for colorimetric signal generation visible to the naked eye without external instrumentation, while the fluorescent properties of quantum dots (QDs) enable multiplexed detection with high quantum yields and photostability superior to organic fluorophores [12, 21]. The selection of a nanomaterial platform dictates the fundamental operational principles of the resulting diagnostic test-whether it relies on optical, electrochemical, magnetic, or mechanical signal readout-and defines its analytical performance characteristics.

Core Nanomaterial Modalities and Their Transduction Principles

Metallic Nanoparticles: Gold and Silver. The most extensively deployed nanomaterials in commercial RDTs, particularly lateral flow immunoassays (LFIAs), are gold nanoparticles. The principle underlying their utility is the phenomenon of surface plasmon resonance (SPR). When visible light interacts with AuNPs, the conduction band electrons undergo coherent oscillation at a specific resonant frequency, leading to strong absorption and scattering of light at particular wavelengths. This absorption is exquisitely sensitive to the size, shape, and local dielectric environment of the nanoparticles. In a typical LFIA, AuNPs are conjugated with detection antibodies; as they accumulate at the test line upon binding to a viral antigen or antibody, the high local density of nanoparticles produces an intense red-to-pink coloration that constitutes the visual readout [5, 21]. The sensitivity of AuNP-based LFIAs can be substantially enhanced through the use of silver enhancement-whereby silver ions are catalytically deposited onto the gold seed particles, amplifying the optical signal [12]. However, conventional AuNP LFIAs have well-documented limitations in sensitivity compared to NAATs, particularly for low viral load specimens or in presymptomatic patients, as demonstrated by meta-analyses of SARS-CoV-2 antigen detection tests which reported pooled sensitivities of only 68% compared to RT-qPCR [24].

To overcome these sensitivity deficits, more advanced nanomaterial labels have been engineered. Latex microspheres (LMs) loaded with colored dyes, such as those used in a dual-color LFIA for African swine fever virus antibody detection, offer enhanced signal intensity and the possibility of multiplexed readout through the use of differently colored beads (e.g., red and blue) on a single strip [5]. This approach achieved a sensitivity of 1:1024 and a Cohen's kappa value of 0.955 when compared to a commercial ELISA, demonstrating that careful nanomaterial selection can bridge the performance gap between simple immunoassays and laboratory-based methods [5]. Similarly, nitrogen-vacancy (NV) centers in nanodiamonds represent a quantum-enhanced labeling strategy. By controlling the spin-dependent fluorescence of NV centers, background autofluorescence from complex clinical matrices (e.g., blood or respiratory secretions) can be removed through spin manipulation, enabling a mean detection of SARS-CoV-2 antigen 2.0 days earlier than conventional AuNP tests and achieving sensitivity of 95.1% for specimens with Ct values ≤30 [7].

Quantum Dots and Upconversion Nanoparticles. Quantum dots are semiconductor nanocrystals that exhibit size-tunable, narrow-band fluorescence emission with broad excitation spectra and exceptional resistance to photobleaching. These properties make them ideal probes for multiplexed viral detection, where different QD populations, each emitting at a distinct wavelength, can simultaneously report on multiple target analytes [12]. For viral RNA detection, QDs conjugated with nucleic acid probes can serve as fluorescent labels in sandwich hybridization assays, providing high signal-to-noise ratios even at picomolar target concentrations [12]. Upconversion nanoparticles (UCNPs), which convert near-infrared (NIR) excitation light to visible emission through a two-photon or multiphoton process, eliminate autofluorescence entirely because biological samples do not exhibit upconversion, resulting in exceptionally low background signals and detection limits in the femtomolar range [3].

Surface-Enhanced Raman Spectroscopy (SERS) Nanoprobes. Surface-enhanced Raman spectroscopy represents a paradigm shift from label-based to label-free molecular detection. SERS exploits the dramatic enhancement of Raman scattering signals (by factors of 10⁶ to 10¹⁴) when molecules are adsorbed onto roughened metal surfaces or arrays of metallic nanoparticles. The enhancement arises from two primary mechanisms: an electromagnetic mechanism resulting from LSPR at the nanostructured surface, which concentrates the incident electromagnetic field, and a chemical charge-transfer mechanism [1, 14]. In the context of viral diagnostics, SERS has been harnessed for the direct identification of viral particles or their molecular signatures. For example, Tran et al. developed a feature-extracted SERS platform using gold nanoparticles on zirconia substrates (Au NPs/fZrO₂ and Au NPs/pZrO₂) for the screening of SARS-CoV-2 in inpatient specimens. By integrating enhanced machine learning (ML) and deep learning (DL) algorithms with SERS spectral analysis, they achieved blind test accuracies of 93.75% for Au NPs/pZrO₂ substrates, demonstrating that the combination of nanomaterial substrate optimization and AI-driven data processing can yield diagnostically relevant performance without the need for target amplification [1]. The principle of SERS-based detection is inherently rapid and can be completed in minutes, positioning it as a promising candidate for real-time, point-of-care (POC) viral screening [14].

Magnetic Nanoparticles. Magnetic nanoparticles (MNPs), typically composed of iron oxide (Fe₃O₄ or γ-Fe₂O₃), offer unique advantages for viral diagnostics. Their superparamagnetic behavior allows them to be magnetized in an external field but retain no residual magnetization once the field is removed, preventing aggregation in the absence of a field. MNPs functionalized with capture antibodies or nucleic acid probes can be used to concentrate viral targets from complex biological matrices (e.g., whole blood, nasal swab eluates, or tissue homogenates) through the application of an external magnetic field, effectively purifying and preconcentrating the target before detection [12, 18]. Furthermore, magnetic relaxation switches-whereby the binding of a target analyte to MNP probes alters the spin-spin relaxation time (T₂) of surrounding water protons-provide a homogeneous, wash-free detection modality that is highly amenable to miniaturized, automated platforms [19].

Carbon-Based Nanomaterials. Carbon nanotubes (CNTs), graphene, and graphene oxide (GO) have been extensively investigated as transducing elements in electrochemical and optical viral biosensors. CNTs possess extraordinary electrical conductivity, high surface-area-to-volume ratios, and exceptional mechanical strength. When functionalized with biorecognition elements (e.g., antibodies or DNA probes), CNT-based field-effect transistors (FETs) can detect attomolar concentrations of viral nucleic acids or proteins through changes in conductance upon target binding [12]. Graphene and its derivatives, particularly GO, exhibit broad-spectrum fluorescence quenching capabilities via Förster resonance energy transfer (FRET) or photoinduced electron transfer (PET). A fluorescent sensor for SARS-CoV-2 oligonucleotides based on carbon dots (CDs) derived from sawdust waste-a green synthetic approach-employed Fe³⁺-mediated fluorescence quenching of CDs, with target-specific recovery of fluorescence upon hybridization, achieving a limit of detection (LOD) of 0.0092 µM and demonstrated excellent selectivity against off-target sequences [2]. This "turn-off/on" fluorescence mechanism is a generalizable principle applicable to any viral nucleic acid for which a complementary probe sequence can be designed [2].

Integration with Nucleic Acid Amplification and Enzymatic Cascade Strategies

The intrinsic detection limits of many nanomaterial-based sensors-often in the picomolar to nanomolar range for proteins and higher for nucleic acids-are insufficient for detecting the extremely low viral loads present in early infection. To address this, nanotechnology has been seamlessly integrated with isothermal nucleic acid amplification techniques, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), which can generate billions of target copies from a single viral genome within 20-60 minutes at a constant temperature [8, 9, 11, 18]. The principle of coupling LAMP with nanomaterial readout is elegantly demonstrated by the PATHPOD system, a POC device that performs real-time reverse-transcription LAMP (RT-LAMP) on a polymer cartridge, with detection monitoring through a total internal reflection (TIR) optical scheme. This system achieved a LOD of 30-50 viral genome copies for SARS-CoV-2 and showed clinical sensitivity and specificity comparable to RT-PCR when validated against 398 clinical samples in hospital settings [9].

A further sophistication of the amplification-nanomaterial interface involves the use of DNA tetrahedron-radiated nanonetworks (DTRNs) for the dual-mode detection of enzymatic activities, such as flap endonuclease 1 (FEN1) or T4 polynucleotide kinase (PNK). In this architecture, a DNA tetrahedron nanoprobe serves as a scaffold for multi-stage rolling circle amplifications (RCAs), which generate long, single-stranded DNA products that are subsequently recognized by hairpin probes, triggering additional rounds of RCA. This exponential amplification cascade ultimately produces a nanonetwork that concurrently generates fluorescent and colorimetric signals, achieving LODs as low as 4.58 × 10⁻³ U mL⁻¹ for FEN1 in fluorescent mode and 2.45 × 10⁻² U mL⁻¹ in colorimetric mode [4]. While demonstrated for enzymatic biomarkers, the principle is directly translatable to the detection of viral enzymes (e.g., proteases or polymerases) or to proxy detection of viral genomes through isothermal amplification of target sequences.

The emergence of CRISPR-Cas systems, particularly Cas12a and Cas13a, has further revolutionized NAAT-based viral detection by providing programmable, sequence-specific recognition coupled with collateral cleavage activity. When combined with nanomaterial reporters-such as fluorophore-quencher pairs on ssDNA or ssRNA probes, or gold nanoparticle aggregation-based colorimetric readouts-CRISPR diagnostics (e.g., SHERLOCK and DETECTR) achieve attomolar sensitivity with single-base specificity [18]. The signal amplification in CRISPR diagnostics is not derived from the Cas enzyme itself but from the coupled isothermal preamplification step (typically RPA or LAMP), while the readout is provided by the nanomaterial reporter. This modular principle-separating target amplification from signal transduction-allows for flexible optimization of each component independently.

The Convergence of Nanotechnology with Artificial Intelligence and Machine Learning

The interpretation of signals from nanostructured sensors, particularly those generating complex spectral or electrochemical data, has been revolutionized by artificial intelligence (AI) and machine learning (ML) [20, 26]. Nanotechnology-based sensors often produce high-dimensional datasets that are challenging to interpret with traditional threshold-based algorithms. For example, the SERS spectral features associated with viral infections can be subtle and obscured by background matrix effects. By training supervised ML models-such as support vector machines (SVM), random forests, or artificial neural networks (ANNs)-on spectral datasets, it becomes possible to classify clinical specimens with accuracies exceeding 93%, even when the raw spectral differences are not apparent to human analysts [1, 6]. The SERA framework, integrating ML with experimental SERS data, predicted key parameters such as resonance shift and molecular binding efficiency, achieving an accuracy of 92% across six classes of analytes [6]. This principle of AI-enhanced nanodiagnostics effectively decouples the complexity of the physical sensing mechanism from the end-user experience, enabling non-specialist operators in field or POC settings to obtain reliable diagnostic results [14].

Principles of Multiplexing, Matrix Compatibility, and Clinical Integration

A critical principle governing the successful deployment of nanotechnology-based RDTs is the ability to perform multiplexed detection of multiple viral pathogens or biomarkers simultaneously. For viruses with overlapping clinical presentations-such as dengefever and chikungunya, or the myriad respiratory viruses-multiplexing is essential for accurate differential diagnosis and appropriate therapeutic intervention [13, 15, 17]. Nanotechnology facilitates multiplexing through spatial encoding (e.g., multiple test lines on a single LFIA strip [21]), spectral encoding (e.g., QDs emitting at different wavelengths [12]), or electrochemical encoding (e.g., distinct redox labels on different electrodes). The dual-color LM-LFIA for African swine fever virus antibody detection exemplifies this approach, using red and blue latex microspheres to provide an intuitive visual readout that simultaneously reports on the presence of target antibody and internal control [5].

Equally important is the principle of matrix compatibility. Biological samples-whether whole blood, serum, plasma, saliva, nasopharyngeal swab eluates, or tissue homogenates from aquatic species-contain a complex mixture of proteins, lipids, carbohydrates, cellular debris, and salts that can interfere with nanomaterial-based detection. For instance, the performance of carbon dot-based fluorescent sensors for SARS-CoV-2 oligonucleotides was shown to depend critically on pH and ionic strength, with optimal results at near-neutral pH [2]. Similarly, the spin-enhanced nanodiamond test for SARS-CoV-2 antigen explicitly addresses matrix interference by exploiting spin-dependent fluorescence that is immune to background autofluorescence common in respiratory samples [7]. The universal principle is that the nanomaterial-biorecognition interface must be robustly passivated and the assay conditions (e.g., buffer composition, incubation time, temperature) optimized to maintain signal integrity across the expected range of sample matrices. The clinical implementation of nanotechnology-based RDTs in veterinary settings also requires rigorous validation against reference methods, using appropriate sample sizes and Bayesian frameworks to prospectively estimate performance metrics with adequate precision [16]. For transboundary animal diseases such as Classical Swine Fever Virus, Foot-and-Mouth Disease Virus, and Infectious Salmon Anemia Virus, the World Organisation for Animal Health (WOAH, formerly OIE) mandates that any RDT intended for official use must demonstrate comparable or superior performance to prescribed reference tests, underscoring the need for rigorous, independent evaluation of nanomaterial-based platforms [22, 25].

Molecular Pathogenesis and Detection Mechanisms: SERS, Fluorescence, and Nanosensor Interactions

The interrogation of viral pathogenesis at the molecular level has increasingly converged with the exquisite sensitivity of nanophotonic and nanoelectronic platforms. For the veterinary clinical pathologist, understanding the fundamental interactions between viral biomolecules-whether surface glycoproteins, capsid antigens, or nucleic acid sequences-and engineered nanostructures is paramount to interpreting diagnostic signals, optimizing assay design, and anticipating limitations in field-deployed rapid tests. This section dissects the underlying biophysical and chemical mechanisms of three principal detection modalities: surface-enhanced Raman spectroscopy (SERS), fluorescence-based nanosensing, and integrated nanosensor platforms (plasmonic, nanomechanical, and electrochemical), with a focus on their application to viral targets of veterinary significance.

Surface-Enhanced Raman Spectroscopy (SERS): Plasmonic Hotspots and Viral Fingerprinting

SERS operates on the principle of enormous electromagnetic field enhancement generated at the surface of noble metal nanostructures (typically gold or silver) when excited by incident light at a wavelength resonant with the localized surface plasmon resonance (LSPR) of the nanoparticle [1, 14, 29]. This enhancement, which can reach factors of (10^6) to (10^{14}), amplifies the otherwise weak Raman scattering signal from molecules adsorbed onto or in close proximity to the nanostructured surface. For viral diagnostics, this translates into the ability to detect the unique vibrational fingerprint of viral proteins, lipids, and nucleic acids without the need for labeling, a paradigm known as label-free SERS [1, 26].

The molecular pathogenesis linkage emerges from the fact that the SERS spectrum reflects the entire biochemical composition of the viral particle or infected cellular material. For instance, the characteristic peaks corresponding to amide I and III bands (protein backbone), tyrosine and tryptophan residues (aromatic amino acids), and phosphodiester stretches (nucleic acids) can discriminate between intact virions and non-infectious debris [6]. The substrate architecture is critical: the use of Au nanoparticles on zirconia (Au NPs/fZrO₂ and Au NPs/pZrO₂) creates a high density of plasmonic "hotspots" where the field enhancement is maximal, enabling the detection of SARS-CoV-2 signature spectra from clinical samples [1]. Critically, the performance of SERS-based viral detection is exquisitely dependent on data processing pipelines. Tran et al. demonstrated that while principal component analysis (PCA) combined with z-score normalization yields the highest validation accuracy ( >98%) for classifying COVID-19 positive from negative specimens, the generalization to independent blind test sets is often superior when using min-max normalization with manual peak selection [1]. This underscores that the biological information content within SERS spectra is not uniformly distributed; manual feature extraction, guided by knowledge of viral molecular structures, can outperform purely data-driven dimensionality reduction.

The integration of machine learning (ML) and deep learning (DL) models further enhances the diagnostic utility of SERS. Support vector machines (SVM) and artificial neural networks (ANN) trained on SERS datasets can achieve blind test accuracies exceeding 90% for viral classification [1, 6]. The proposed SERA framework, which couples experimental SERS data with supervised learning, can predict key parameters such as resonance shift and molecular binding efficiency, enabling real-time adaptive sensing [6]. This AI-driven approach is particularly relevant for the emergence of viral variants; as the surface proteome mutates-as observed with Avian Influenza Virus hemagglutinin or Newcastle Disease Virus fusion protein-the SERS fingerprint may shift, and ML models must be retrained to maintain classification fidelity. The veterinary pathologist must therefore recognize that SERS is not a static "lock-and-key" method but a dynamic, spectro-informatic discipline where substrate design, signal preprocessing, and algorithmic training are inseparably linked to diagnostic accuracy.

Fluorescence-Based Detection: Quantum Dots, Carbon Dots, and Förster Resonance Energy Transfer (FRET)

Fluorescence-based nanosensors offer an alternative paradigm, trading the broadband fingerprint of SERS for the high signal-to-noise ratio of specific photoluminescent probes. The mechanisms at play range from simple "turn-off/turn-on" quenching to sophisticated Förster resonance energy transfer (FRET) and spin-dependent quantum readout. A particularly elegant illustration of the former is the use of waste-derived carbon dots (CDs) for detecting SARS-CoV-2 oligonucleotide sequences [2]. Here, the fluorescence of nitrogen-doped CDs (quantum yield 35.9%) is quenched by Fe³⁺ ions via a static quenching mechanism. The addition of the target viral RNA-specifically the ORF1ab region-restores fluorescence because the negatively charged phosphate backbone of the nucleic acid competes for Fe³⁺ binding more effectively than the carboxyl/hydroxyl groups on the CD surface [2]. This turn-on mechanism yields a linear detection range of 0.10 to 1.5 µM with a limit of detection (LOD) of 9.2 nM. The selectivity is remarkable; the sensor can distinguish between SARS-CoV-2 and SARS-CoV target sequences, a feat achieved through both thermodynamic competition and hybridization specificity. The clinical implication for veterinary virology is profound: this platform, requiring no sophisticated instrumentation, could be adapted for the rapid detection of Infectious Salmon Anemia Virus or White Spot Syndrome Virus in field settings, provided that sequence-specific probes are designed against conserved genomic regions.

At the quantum frontier, nitrogen-vacancy (NV) centers in nanodiamonds have been harnessed for spin-enhanced lateral flow assays (LFA) [7]. This technology exploits the quantum mechanical property that the fluorescence intensity of NV centers is dependent on the spin state, which can be controlled via microwave radiation. By modulating the spin state and collecting only the difference in fluorescence between the "on" and "off" states, the background from complex clinical matrices (e.g., blood, nasal mucus) is effectively subtracted [7]. DeCruz et al. applied this concept to SARS-CoV-2 antigen detection in 103 clinical samples, achieving 95.1% sensitivity (for Ct ≤30) and 100% specificity, with a mean detection time 2.0 days earlier than conventional gold nanoparticle-based LFAs [7]. The mechanistic beauty lies in the "optical multiplexing" of quantum control: the nanodiamonds serve as both the reporter and the filter, a feat impossible with classical fluorophores that suffer from photobleaching and autofluorescence. For veterinary applications, this could revolutionize the detection of low-titer viruses such as Bovine Viral Diarrhea Virus in persistently infected animals, where antigen levels are often near the LOD of conventional assays.

More complex fluorescent architectures employ DNA nanotechnology to create signal amplification networks. The DNA tetrahedron-radiated nanonetwork (DTRN) is a prime example, integrating multi-stage rolling circle amplification (RCA) to detect flap endonuclease 1 (FEN1) and T4 polynucleotide kinase (PNK) activities [4]. While initially developed for cancer biomarkers, the principle is directly transferable to viral pathogen detection. The system is initiated by a viral-specific recognition event (e.g., binding of a viral DNA/RNA sequence to a toehold domain on the tetrahedron), which triggers a ligation reaction that, in turn, primes first-stage RCA. The resulting long single-stranded DNA with repetitive sequences then hybridizes with hairpin probes, initiating second-stage RCAs from multiple sites simultaneously, creating a dense fluorescent nanonetwork [4]. The exponential amplification yields LODs as low as (5.76 \times 10^{-4} , \text{U mL}^{-1}) in fluorescent mode, with a colorimetric readout providing orthogonal validation. This dual-mode capability is critical for confirmatory testing in veterinary diagnostics, where the cost of false positives (e.g., culling decisions for African Swine Fever Virus) is catastrophic.

Plasmonic and Nanosensor Integration: LSPR, Nanomechanical Cantilevers, and Electrochemical Transduction

Beyond isolated SERS and fluorescence, the field is advancing toward integrated nanosensor platforms that transduce viral binding events into electrical, mechanical, or optical signals with unmatched sensitivity. Localized surface plasmon resonance (LSPR) sensors, often combined with SERS in a single platform, detect shifts in the plasmon resonance wavelength upon viral adsorption [14]. These shifts are exquisitely sensitive to the refractive index change at the nanoparticle surface caused by the binding of high-molecular-weight viral particles. The incorporation of ML for predictive modeling of resonance shifts can reduce the need for extensive trial-and-error optimization of sensor design, accelerating test development for emerging viruses [6].

Nanomechanical cantilever-based biosensors represent a fundamentally different transduction mechanism: they detect the bending or change in resonant frequency of a microscale cantilever beam due to the mass of bound viral antigens. Samuel et al. demonstrated this for HIV-1 p24 antigen detection using microcantilevers functionalized with broadly cross-reactive monoclonal antibodies (ANT-152 and C65690M) [27]. The platform achieved a LOD of 100 fg/mL in buffer and 1 pg/mL in human serum, with a dynamic range spanning several orders of magnitude. The mechanism relies on the stress induced on the cantilever surface upon antigen-antibody binding, which is proportional to the analyte concentration. For veterinary virology, this label-free, real-time detection could enable the instantaneous monitoring of Foot-and-Mouth Disease Virus in livestock trade, where rapid diagnosis is critical for quarantine decisions.

Electrochemical nanosensors, particularly those leveraging two-dimensional nanomaterials like MXenes (Ti₃C₂Tₓ), offer yet another transduction modality. Bolourinezhad et al. developed a DNA/RNA hybridization sensor on a screen-printed electrode modified with MXene/Pt/C nanocomposite [28]. Upon hybridization of a capture probe with the SARS-CoV-2 RdRp gene target, the differential pulse voltammetry (DPV) signal increased with a positive slope, yielding a LOD of 0.4 aM and 100% accuracy on 192 clinical samples [28]. The mechanism involves the high electrical conductivity and large surface area of MXene providing a dense loading of probe DNA, while Pt nanoparticles catalyze the redox reaction of the intercalated mediator. The veterinary clinical pathologist should note that this platform can be adapted to detect any RNA virus by simply redesigning the capture probe-a flexibility that is invaluable for monitoring diverse pathogens such as Porcine Reproductive and Respiratory Syndrome Virus or Canine Distemper Virus.

The convergence of these mechanisms is perhaps best exemplified by the "Lab-on-PCB" approach, where isothermal amplification (RT-LAMP) is integrated with electrochemical detection on a printed circuit board [8]. This system achieves nucleic acid amplification and detection of SARS-CoV-2 at 10 copies/reaction within 1.5 hours, using a compact electronic readout costing less than $10 USD. The underlying biophysics involves the intercalation of a redox-active dye (e.g., methylene blue) into double-stranded amplicons, which modulates the cyclic voltammetry current [8]. For the practicing pathologist, this represents a paradigm shift from centralized PCR labs to truly decentralized, herd-level surveillance, particularly for pathogens like Infectious Bursal Disease Virus in poultry or Koi Herpesvirus in aquaculture. The critical pathophysiological insight is that these sensors do not merely detect the presence of a pathogen; they quantify the molecular burden, which correlates with infectivity, stage of disease, and risk of transmission.

Protocol and Methodology for Nanomaterial Synthesis and Assay Development

The translation of nanomaterial-based diagnostics from benchtop innovation to clinically validated rapid viral diagnostic tests demands a rigorous, standardized framework for synthesis, characterization, and assay integration. As a veterinary clinical pathologist, I emphasize that the biological matrix-whether serum, whole blood, nasopharyngeal swab, or tissue homogenate from livestock, poultry, aquatic species, or companion animals-imposes constraints that must be anticipated at the earliest stages of nanomaterial design. The protocols described herein synthesize insights from 81 peer-reviewed studies to establish a comprehensive methodological pipeline, spanning nanomaterial selection and synthesis, biorecognition element conjugation, signal transduction optimization, and assay validation against reference standards.

1. Nanomaterial Selection and Synthetic Routes

The choice of nanomaterial dictates the fundamental operating principles of the diagnostic assay-optical, electrochemical, or magnetic-and must be matched to the target pathogen's biology, the sample matrix, and the required limit of detection (LOD). For surface-enhanced Raman scattering (SERS)-based platforms, the synthesis of plasmonic substrates requires precise control over nanoparticle size, shape, and interparticle spacing. Tran et al. [1] demonstrated that gold nanoparticles (Au NPs) deposited on fluorinated zirconia (fZrO₂) and pristine zirconia (pZrO₂) substrates yield distinct SERS enhancement factors, with Au NPs/fZrO₂ providing superior signal-to-noise ratios for SARS-CoV-2 signature spectra. The synthetic protocol involved citrate reduction of HAuCl₄ under reflux, followed by electrostatic assembly onto zirconia supports. Critical parameters include pH (maintained at 6.5-7.0), reaction temperature (95-100°C), and stirring rate (300-400 rpm), as deviations produce polydisperse populations that degrade spectral reproducibility. Post-synthesis, substrates underwent rigorous cleaning via sequential sonication in ethanol and deionized water, then argon plasma treatment to remove organic contaminants [1]. For green synthesis approaches, hydrothermal routes using biowaste-derived precursors offer sustainable alternatives. Torre et al. [2] produced waste-derived carbon dots (CDs) from sawdust via hydrothermal carbonization at 200°C for 12 hours, achieving a quantum yield of 35.9%. The sawdust precursor was first washed, dried, and ground to a fine powder, then suspended in deionized water and transferred to a Teflon-lined stainless-steel autoclave. After cooling, the dark-brown solution was filtered through 0.22-μm membranes and dialyzed against deionized water for 48 hours to remove unreacted species. The resulting CDs exhibited excitation-dependent fluorescence centered at 450 nm, ideal for turn-off/on sensing of viral oligonucleotides via Fe³⁺-mediated quenching [2]. Similarly, duck-feather keratin extracted hydrothermally at pH 11 and 70°C functioned simultaneously as reducing and capping agent for silver nanoparticles (AgNPs), producing spherical particles averaging 11 nm with excellent long-term colloidal stability [30]. This waste-valorizing route eliminates the need for external chemical reductants, reducing batch-to-batch variability-a critical advantage for Good Manufacturing Practice (GMP)-compliant production.

For quantum-enhanced diagnostics, nitrogen-vacancy (NV) centers in nanodiamonds (NDs) represent a transformative label. DeCruz et al. [7] described the synthesis of 100-nm fluorescent NDs via high-pressure high-temperature (HPHT) milling, followed by oxygen surface termination and subsequent functionalization with streptavidin. The NV centers enable spin-dependent fluorescence readout, suppressing background autofluorescence from complex clinical matrices such as nasopharyngeal swabs. The synthetic protocol included acid cleaning in a 3:1 H₂SO₄:HNO₃ mixture at 80°C for 4 hours to remove graphitic carbon, then silanization with (3-aminopropyl)triethoxysilane (APTES) to introduce amine groups for subsequent bioconjugation [7]. For electrochemical platforms, MXene nanosheets (Ti₃C₂Tₓ) synthesized via selective etching of Al layers from Ti₃AlC₂ MAX phase using 49% HF at room temperature for 24 hours provide high electrical conductivity and large surface area for probe immobilization. Bolourinezhad et al. [28] exfoliated MXene nanosheets via ultrasonic treatment in dimethyl sulfoxide (DMSO) for 1 hour, then mixed with platinum-decorated carbon (Pt/C) at a 1:1 mass ratio to amplify the electrochemical signal from DNA/RNA hybridization. The composite was drop-cast onto screen-printed carbon electrodes and dried at 37°C for 30 minutes, producing a stable, porous sensing film [28]. For lateral flow immunoassays (LFIAs), latex microspheres (LMs) doped with distinct chromophores enable multiplexed detection. Chen et al. [5] synthesized red LMs (RLMs) and blue LMs (BLMs) via emulsion polymerization using styrene and methacrylic acid as monomers, with Sudan Red 7B and Pigment Blue 15:3 as chromophores. Particle size was controlled to 200-300 nm to ensure optimal capillary flow on nitrocellulose membranes. The p72 protein of African Swine Fever Virus was covalently conjugated to RLMs via carbodiimide chemistry, while chicken IgY was conjugated to BLMs as a control line label, enabling dual-color visual readout within 15 minutes [5].

2. Biorecognition Element Conjugation and Functionalization

The attachment of antibodies, aptamers, or nucleic acid probes to nanomaterial surfaces must preserve biomolecular activity while maximizing surface loading density. For antibody conjugation, the most widely adopted chemistry involves carbodiimide-mediated amide bond formation between carboxylated nanoparticles and primary amines on the antibody's Fc region. Santos-Silva et al. [31] functionalized polymeric nanoparticles (200 nm) with monoclonal antibodies targeting conserved regions of the Hepatitis E Virus ORF2 capsid protein. The protocol employed 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) at a 2:1 molar ratio in 50 mM MES buffer (pH 6.0), with a 30-minute activation step at room temperature. Antibodies were added at a 10:1 w/w ratio (nanoparticle:antibody) and incubated for 2 hours at 25°C with gentle shaking. Unreacted sites were blocked with 1% bovine serum albumin (BSA) for 30 minutes, then the nanoparticles were washed three times via centrifugation at 15,000 × g for 20 minutes and resuspended in storage buffer (10 mM PBS, pH 7.4, 0.1% BSA, 0.02% sodium azide) [31]. For aptamer-based systems, Martin et al. [32] employed SELEX-derived DNA aptamers targeting the Ebola virus nucleoprotein (NP). The aptamers (Apt1, Apt2, Apt3) were synthesized with a 5'-amine modification and coupled to carboxylated magnetic beads using the same EDC/NHS chemistry. Critical to this protocol was the inclusion of a 12-carbon spacer (C12) between the amine and aptamer sequence to reduce steric hindrance and enhance target accessibility. Binding affinity was confirmed via microscale thermophoresis (MST), yielding dissociation constants (Kd) of 25 ± 2.84 nM for Apt1, 56 ± 2.76 nM for Apt2, and 140 ± 3.69 nM for Apt3, in agreement with molecular dynamics simulations [32].

For nucleic acid detection platforms, probe design must account for secondary structure, melting temperature (Tm), and specificity against closely related pathogens. Bolourinezhad et al. [28] designed a 25-nucleotide DNA probe targeting the RdRp gene of SARS-CoV-2, with a Tm of 58°C and minimal hairpin formation predicted by mFold software. The probe was immobilized onto MXene/Pt/C-modified electrodes via physical adsorption at 37°C for 1 hour, followed by washing with 0.1% SDS to remove unbound oligonucleotides [28]. For isothermal amplification-based assays, primer sets for reverse-transcription loop-mediated isothermal amplification (RT-LAMP) must be designed against conserved genomic regions. Nguyen et al. [9] developed RT-LAMP primers targeting the ORF1ab and N genes of SARS-CoV-2, with primer lengths of 18-24 nucleotides and GC content of 40-60%. The primers were synthesized with a 6-carboxyfluorescein (FAM) label on the inner primer for real-time fluorescence monitoring via total internal reflection (TIR) optics [9]. To eliminate carryover contamination-a persistent challenge in LAMP-based point-of-care (POC) testing-Quyen et al. [33] incorporated cod uracil-DNA-glycosylase (Cod-UNG) into the reaction mixture. The Cod-UNG enzyme digests uracil-containing amplicons from previous runs, while leaving native DNA intact. The optimized Cod-UNG-rRT-LAMP protocol included 0.5 U Cod-UNG per 25-μL reaction, with a 10-minute incubation at 37°C prior to amplification to degrade contaminating amplicons, followed by enzyme inactivation at 95°C for 5 minutes [33].

3. Assay Architecture and Signal Transduction Mechanisms

The integration of nanomaterials into functional assays requires careful optimization of reagent concentrations, incubation times, and signal readout parameters. For SERS-based diagnostics, spectral preprocessing is paramount. Tran et al. [1] established a standardized pipeline: (i) cosmic spike removal using median filtering, (ii) baseline correction via asymmetric least squares (λ = 10⁵, p = 0.001), (iii) Savitzky-Golay smoothing (window size 7, polynomial order 3), and (iv) statistical outlier elimination based on Hotelling's T² and Q-residual analysis at 95% confidence intervals. Multiple normalization strategies-none, min-max, and z-score-were compared, with z-score normalization combined with principal component analysis (PCA) yielding the highest validation accuracy (>98%) for SARS-CoV-2 classification. However, min-max normalization with manual peak selection demonstrated superior generalization in blind testing (87.5% accuracy for Au NPs/fZrO₂ substrates) [1]. For machine learning (ML)-enhanced SERS, Pandey et al. [6] trained supervised learning algorithms on the SERS-DB spectral dataset (420 training samples, 180 testing samples across 6 classes) to predict resonance shifts and molecular binding efficiency. The SERA framework achieved 92% accuracy, 90% precision/recall, and an F1-score of 92%, with sensitivity of 1000 nm/RIU and optimization efficiency of 95% [6]. This methodology enables real-time adaptive sensing without extensive trial-and-error experimentation.

For fluorescence-based turn-off/on sensors, the detection of viral oligonucleotides relies on competitive binding between Fe³⁺ ions and the target sequence. Torre et al. [2] optimized the CD-Fe³⁺ system by incubating 50 μg/mL CDs with 100 μM FeCl₃ in 10 mM HEPES buffer (pH 7.4) for 5 minutes, achieving >90% fluorescence quenching. Upon addition of the target ORF1ab-SARS-CoV-2 oligonucleotide (0.10-1.5 μM), fluorescence recovery reached 85% within 10 minutes, with a LOD of 0.0092 μM and LOQ of 0.031 μM. Matrix effect studies revealed that detection performance depends critically on pH and ionic strength: optimal results were obtained at pH 7.4 and moderate conductivity (50-100 mM NaCl), while deviations >20% reduced recovery efficiency [2]. For nanodiamond-based LFIAs, DeCruz et al. [7] employed a spin-enhanced readout protocol wherein an external microwave field (2.87 GHz) is applied to modulate NV-center fluorescence. The test line intensity is extracted by subtracting the microwave-off from the microwave-on signal, effectively removing background autofluorescence. The assay achieved 95.1% sensitivity for Ct ≤ 30 and 100% specificity in 103 clinical samples, with detection occurring 2.0 days earlier than conventional gold nanoparticle LFIAs [7].

Electrochemical detection via differential pulse voltammetry (DPV) offers quantitative readout with high temporal resolution. Bolourinezhad et al. [28] optimized DPV parameters: potential range −0.4 to +0.8 V, pulse amplitude 50 mV, pulse width 50 ms, and scan rate 25 mV/s. The calibration curve for SARS-CoV-2 RdRp target exhibited a positive slope with correlation coefficient R² = 0.9977 across 1 aM to 100 nM, yielding LOD of 0.4 aM. In 192 clinical samples, the biosensor achieved 100% sensitivity, 97.87% specificity, and LOQ of 60 copies/mL, with no cross-reactivity against influenza A, respiratory syncytial virus, or rhinovirus [28]. For lab-on-PCB systems, Muralidharan et al. [8] integrated RT-LAMP amplification with cyclic voltammetry (CV) detection using a redox-active intercalator (methylene blue, 50 μM). The CV scan was performed at 50 mV/s from −0.6 to +0.2 V, with the peak current at −0.25 V correlating with amplicon concentration. The system detected 10 copies/reaction within 1.5 hours, with hardware costs under USD 10 [8].

4. Amplification Strategies for Enhanced Sensitivity

For direct detection of low-abundance viral nucleic acids, isothermal amplification methods have been adapted to nanomaterial platforms. The PATHPOD system [9] employs real-time RT-LAMP on a polymer cartridge with total internal reflection (TIR) optics. The reaction mixture contains 1× Isothermal Master Mix, 0.2 μM each of F3/B3 primers, 1.6 μM each of FIP/BIP primers, 0.8 μM of loop primers, 1 mM dNTPs, 8 mM MgSO₄, 0.5 M betaine, 1 U/μL WarmStart RTx, and 0.5× EvaGreen dye. Amplification proceeds at 65°C for 45 minutes, with fluorescence monitored every 30 seconds. LOD is 30-50 viral genome copies, with clinical sensitivity and specificity of 98.2% and 95.2%, respectively, compared to RT-PCR [9, 33]. For recombinase polymerase amplification (RPA), Cherkaoui et al. [11] developed a one-pot multi-gene RT-RPA assay targeting the E and RdRP genes of SARS-CoV-2. The reaction includes 29.5 μL rehydration buffer, 2.1 μL forward primer (10 μM), 2.1 μL reverse primer (10 μM), 0.6 μL TwistAmp exo probe (10 μM), 5 μL template RNA, and 2.5 μL 280 mM magnesium acetate to initiate the reaction. Incubation at 42°C for 20 minutes yields detectable fluorescence, with 96% sensitivity and 97% specificity in 91 clinical samples. Critically, the assay detected all 11 tested SARS-CoV-2 lineages, including Alpha, Beta, Delta, and Omicron variants [11].

Rolling circle amplification (RCA) combined with DNA tetrahedron nanostructures enables exponential signal enhancement. Cui et al. [4] constructed a DNA tetrahedron-radiated nanonetwork (DTRN) with four first-stage trigger sequences for multi-stage RCA. The DNA tetrahedron was assembled from four oligonucleotides (96 bases each) via thermal annealing (95°C for 2 minutes, then 4°C for 30 minutes). Upon target recognition by FEN1 or T4 PNK, circular templates are formed via ligation, initiating RCA at 30°C for 2 hours using phi29 DNA polymerase. The resulting long single-stranded DNAs contain repetitive sequences that hybridize with hairpin probes to initiate second-stage RCA, generating a nanonetwork with concomitant fluorescence and UV-vis absorption signals. The LOD reached 4.58 × 10⁻³ U/mL for FEN1 and 5.76 × 10⁻⁴ U/mL for T4 PNK in fluorescent mode, with dual-mode detection enabling mutual verification [4].

5. Integration of Machine Learning and Artificial Intelligence

Modern nanomaterial-based assays increasingly incorporate ML/DL algorithms for spectral classification, signal denoising, and predictive modeling. Tran et al. [1] compared support vector machine (SVM) classifiers with k-fold cross-validation (k = 5) against artificial neural network (ANN)-based deep learning models. The ANN architecture comprised three hidden layers (64, 32, and 16 nodes) with ReLU activation, dropout (0.2), and a softmax output layer. Training used Adam optimizer (learning rate 0.001) with categorical cross-entropy loss, batch size 32, and early stopping (patience 10 epochs). The ANN achieved blind test accuracies of 93.75% for Au NPs/pZrO₂ and 87.50% for Au NPs/fZrO₂ substrates [1]. For host-response-based diagnostics, Iglesias-Ussel et al. [15] developed a rapid blood test (HR-B/V) that measures peripheral blood gene expression to discriminate bacterial vs. viral infections. The assay uses Biomeme's PCR-based Franklin platform with a 29-gene panel, and ML models (random forest) achieve 84.5% accuracy, with positive percent agreement of 88.5% and negative percent agreement of 83.1% for bacterial infection detection [15]. This approach has direct applicability to veterinary settings where rapid differentiation of Avian Influenza Virus from bacterial respiratory pathogens is critical for outbreak management.

6. Quality Control and Validation Protocols

Rigorous quality control (QC) is essential at every stage of nanomaterial synthesis and assay development. For nanoparticle batches, key QC parameters include: (i) hydrodynamic diameter and polydispersity index (PDI) via dynamic light scattering (DLS), with acceptance criteria of PDI < 0.2; (ii) zeta potential (ζ) via electrophoretic light scattering, with

Data Preprocessing, Feature Extraction, and Machine Learning Classification in SERS-Based Diagnostics

The translation of raw surface-enhanced Raman spectroscopy (SERS) data into clinically actionable diagnostic results necessitates a rigorous, multi-stage computational pipeline. As a veterinary clinical pathologist, I must emphasize that the spectral data generated from SERS substrates-whether colloidal nanoparticles, nanostructured surfaces, or hybrid platforms-are inherently complex, replete with both biological information and non-specific interferences. The fidelity of any diagnostic classification, particularly for rapid viral detection, depends critically on the orchestrated execution of data preprocessing, feature extraction, and machine learning (ML) classification. This section provides an exhaustive analysis of these computational methodologies, drawing upon the latest advancements in the field and contextualizing them within the exigent demands of veterinary and zoonotic viral diagnostics.

Foundational Data Preprocessing: From Raw Spectra to Analytical Signals

The initial raw SERS spectrum is a convolution of the true molecular fingerprint of the target virus, substrate-enhanced signals, and numerous artifacts. The preprocessing phase is therefore non-negotiable for ensuring data integrity and comparability across samples, a principle well-established in the analysis of Avian Influenza Virus and other respiratory pathogens [1, 14, 26]. The canonical preprocessing workflow begins with cosmic spike removal, a critical step to eliminate high-intensity, narrow-bandwidth artifacts caused by incident cosmic radiation striking the charge-coupled device (CCD) detector. Failure to remove these stochastic events can introduce spurious peaks that subsequently confound feature extraction algorithms [1]. Following this, baseline correction is applied to subtract the broad, slowly varying fluorescence background that is ubiquitous in biological specimens. Polynomial fitting algorithms, typically of the third to sixth order, or more advanced methods such as asymmetric least squares (ALS), are employed to estimate and remove this background, revealing the true Raman peaks that represent vibrational modes of viral proteins, lipids, and nucleic acids [1, 14]. The subsequent application of Savitzky-Golay smoothing serves to reduce high-frequency noise while preserving the spectral line shape, a crucial step for enhancing the signal-to-noise ratio (SNR) without distorting peak position or width [1].

Normalization is perhaps the most pivotal preprocessing decision, as it directly governs the quantitative comparability of spectra collected under varying conditions. Tran et al. (2026) systematically evaluated multiple normalization strategies for SARS-CoV-2 detection using SERS, demonstrating that the choice profoundly impacts classifier performance [1]. Three primary approaches are employed: (1) none, where raw intensity values are used; (2) min-max normalization, which scales each spectrum to a [1] range; and (3) z-score normalization (also termed autoscaling), which centers the data to a mean of zero and scales it to unit variance [1]. For veterinary applications, where sample matrices vary dramatically-from poultry cloacal swabs in Newcastle Disease Virus surveillance to fin clips in Infectious Hematopoietic Necrosis Virus diagnostics-the normalization strategy must be robust to matrix-induced intensity fluctuations. Z-score normalization, while effective for multivariate statistical methods like Principal Component Analysis (PCA) due to its variance-stabilizing properties, can amplify noise in low-intensity regions [1]. Conversely, min-max normalization preserves relative peak intensity relationships, which can be advantageous for diagnostic models relying on specific biochemical signatures, as demonstrated in the superior blind test performance of models using min-max normalization with manual peak selection [1]. An additional critical preprocessing step is statistical outlier elimination, often performed using Hotelling's T² and Q-residual analysis within a PCA framework [1]. This multivariate approach identifies spectra that are statistically anomalous-perhaps due to substrate defects, sample aggregation, or contamination-and removes them from the training dataset, thereby preventing model corruption.

Feature Extraction: Dimensionality Reduction and Biochemical Insight

Given that a single SERS spectrum may contain hundreds to thousands of wavenumber variables, direct classification with raw, high-dimensional data is computationally prohibitive and prone to overfitting, a phenomenon known as the “curse of dimensionality.” Feature extraction serves to distill the most diagnostically relevant information from the spectral data, reducing dimensionality while preserving biological signal [1, 6, 26]. The three principal approaches evaluated in modern SERS-based viral diagnostics are: full-spectrum analysis, manual peak selection, and unsupervised dimensionality reduction.

Full-spectrum analysis retains all spectral variables, providing a comprehensive, unbiased representation of the data. While this approach carries the maximal information content, it is highly susceptible to noise and often requires sophisticated, regularized classifiers to prevent overfitting [1]. In contrast, manual peak selection is a knowledge-driven approach where the spectral regions corresponding to known vibrational modes of viral biomarkers-such as amide I (1650-1680 cm⁻¹) and amide III (1200-1300 cm⁻¹) bands of viral capsid proteins, or phosphate backbone vibrations (1080-1100 cm⁻¹) of viral RNA-are identified and used as input features [14, 26]. This method offers superior interpretability and, critically, generalization performance. Tran et al. (2026) demonstrated this explicitly: while z-score normalization combined with PCA yielded the highest validation accuracy (>98%), min-max normalization with manual peak selection achieved superior blind test accuracies of 87.5% and 75% for two distinct SERS substrates [1]. This finding underscores the principle that models trained on biologically meaningful, investigator-curated features are more robust when encountering heterogeneous clinical specimens, a scenario typical of field-deployed diagnostic tests for pathogens like African Swine Fever Virus or Foot-and-Mouth Disease Virus.

Principal Component Analysis (PCA) is the most widely employed unsupervised feature extraction method in SERS diagnostics [1, 6, 26]. PCA transforms the high-dimensional spectral data into a set of orthogonal, uncorrelated principal components (PCs), each representing the direction of maximum variance in the dataset. The first few PCs typically capture the majority of systematic variance attributable to biological differences (e.g., presence vs. absence of virus), while later PCs often represent noise. By retaining only the significant PCs, PCA effectively compresses the spectral data, removes collinearity, and provides a reduced feature space ideally suited for subsequent classification [1, 6]. In the context of viral diagnostics, the PC scores can be visualized in a 2D or 3D score plot, allowing for rapid visual discrimination between infected and uninfected samples, a technique particularly valuable for screening large numbers of samples in outbreak scenarios, such as those involving White Spot Syndrome Virus in shrimp aquaculture. The loading vectors of the PCs further provide biochemical interpretability, revealing which wavenumbers (and thus which molecular bonds) contribute most to the separation between classes [14].

Machine Learning Classification: From Training to Clinical Deployment

The culmination of the SERS-based diagnostic pipeline is the application of supervised ML algorithms to build a predictive model capable of classifying unknown samples as either virus-positive or virus-negative [1, 20, 26]. The choice of classifier, coupled with rigorous training and validation protocols, is paramount for achieving the high sensitivity and specificity demanded by clinical veterinary diagnostics.

Support Vector Machine (SVM) classifiers are a cornerstone of SERS-based diagnostics, renowned for their efficacy in high-dimensional, non-linear classification problems [1, 6, 26]. The fundamental principle of SVM is to construct an optimal separating hyperplane that maximizes the margin between two classes (e.g., infected vs. non-infected) in a transformed feature space. For non-linearly separable data, a kernel function-most commonly the radial basis function (RBF) kernel-is used to project the data into a higher-dimensional space where linear separation becomes possible [1]. In the study by Tran et al. (2026), SVM classifiers were trained using k-fold cross-validation (typically 5- or 10-fold) on the preprocessed and feature-extracted SERS data [1]. This approach partitions the training data into k subsets, iteratively trains the model on k-1 subsets, and validates on the held-out subset, providing a robust estimate of model performance and mitigating overfitting. The study further assessed generalization via independent blind testing on separate inpatient samples, a practice that mirrors the clinical reality of deploying a test on a population distinct from the training cohort [1]. The results were revealing: while PCA+z-score preprocessing yielded peak validation accuracy, the SVM model trained on min-max normalized, manually selected peaks demonstrated superior generalization on the blind test set [1]. This reinforces a critical lesson for veterinary applications: a model that performs flawlessly on a curated training set may fail when confronted with the biological and technical variability inherent in field samples from diverse host species, such as differentiating Canine Parvovirus variants (CPV-2a, 2b, 2c) or distinguishing Feline Coronavirus and FIP from other enteric pathogens.

Artificial Neural Networks (ANNs) and Deep Learning (DL) have emerged as powerful alternatives to traditional ML classifiers, offering the ability to learn hierarchical feature representations directly from the data [1, 20, 26]. Unlike SVM, which requires explicit feature engineering (e.g., PCA scores or selected peaks), deep learning models, particularly those with multiple hidden layers, can automatically discover complex, non-linear relationships between spectral inputs and diagnostic outcomes. Tran et al. (2026) implemented an ANN-based DL model that achieved optimal blind test accuracies of 93.75% for one substrate type and 87.50% for another, surpassing the performance of the best SVM models [1]. This suggests that DL architectures may be particularly adept at capturing subtle, distributed spectral signatures that are not captured by manual peak selection or linear PCA. The application of deep learning to SERS data is a rapidly expanding frontier, with architectures like convolutional neural networks (CNNs) being explored for end-to-end classification of raw or minimally preprocessed spectra [20, 26]. In the context of veterinary diagnostics, DL models could potentially be trained to simultaneously differentiate between multiple viral pathogens that cause similar clinical syndromes, such as the respiratory viruses Avian Metapneumovirus, Infectious Bronchitis Virus, and Newcastle Disease Virus in chickens, or differentiating Porcine Reproductive and Respiratory Syndrome Virus from Swine Influenza A Virus in swine.

Class Imbalance and Performance Metrics are critical considerations in clinical diagnostics. In real-world settings, the prevalence of a specific viral infection in a sampled population may be low (e.g., 5-10%), leading to a severe class imbalance in the training data. If unaddressed, ML classifiers can become biased toward the majority class (negative samples), achieving high apparent accuracy but failing to detect true positives-a catastrophic outcome for infectious disease control [20]. Techniques to mitigate this include oversampling the minority class (e.g., using Synthetic Minority Over-sampling Technique, SMOTE), under-sampling the majority class, or employing cost-sensitive learning where misclassifying a positive sample incurs a higher penalty. Furthermore, reporting raw accuracy is insufficient; comprehensive performance evaluation requires metrics such as sensitivity (true positive rate), specificity (true negative rate), positive predictive value (PPV), negative predictive value (NPV), and the area under the receiver operating characteristic curve (AUROC) [1, 20]. The development of the SERA framework (Surface-Enhanced Raman Spectroscopy AI), which integrates ML for predictive modeling of plasmonic sensing performance, exemplifies the trend toward holistic, AI-driven optimization of the entire SERS diagnostic workflow, from substrate design to clinical classification [6].

In summary, the successful deployment of SERS-based rapid diagnostic tests for viral diseases hinges on a symbiotic relationship between experimental nanoscience and computational data science. The preprocessing, feature extraction, and ML classification steps are not merely ancillary data handling procedures; they are integral components of the diagnostic pipeline, each requiring careful optimization to achieve the sensitivity, specificity, and robustness necessary for clinical and field applications. The convergence of advanced ML models, particularly deep learning, with the high-dimensional, information-rich data provided by SERS holds immense promise for the next generation of rapid, point-of-care viral diagnostic platforms, capable of addressing the challenges posed by emerging and re-emerging veterinary pathogens.

Clinical Application and Performance Evaluation of Nanotechnology-Driven Viral Tests

The translation of nanotechnology-based viral diagnostic platforms from benchtop development to clinical deployment represents a critical juncture in veterinary and human medicine. As a veterinary clinical pathologist, I have witnessed the profound impact that rapid, accurate, and field-deployable diagnostics can have on outbreak management, individual patient care, and population-level surveillance. Nanotechnology-driven tests-encompassing nanosensors, nanoparticle-enhanced lateral flow assays, quantum dot-based platforms, and nanomaterial-enabled electrochemical biosensors-offer transformative potential, but their clinical utility is contingent upon rigorous performance evaluation in real-world settings. This section provides an exhaustive analysis of the clinical application and performance characteristics of these emerging technologies, drawing upon a comprehensive synthesis of recent literature and drawing parallels across multiple viral pathogens of veterinary and zoonotic significance.

2.1 Clinical Translation of Nanotechnology-Enhanced Rapid Diagnostic Platforms

The clinical application of nanotechnology-driven viral diagnostics has advanced most dramatically in the context of the COVID-19 pandemic, which served as an unprecedented accelerator for innovation in point-of-care testing. However, the principles established for SARS-CoV-2 detection are broadly applicable to veterinary pathogens, including Avian Influenza Virus, African Swine Fever Virus, Porcine Reproductive and Respiratory Syndrome Virus, and numerous aquatic viruses such as Infectious Salmon Anemia Virus and White Spot Syndrome Virus. The fundamental challenge remains the same: achieving a limit of detection that approaches or matches reference standards (RT-qPCR or virus isolation) while maintaining the operational simplicity required for deployment in livestock barns, aquaculture facilities, wildlife surveillance programs, and resource-limited veterinary practices.

A landmark clinical evaluation of a spin-enhanced nanodiamond lateral flow test for SARS-CoV-2 antigen detection demonstrated the potential of quantum-enabled diagnostics to address the sensitivity gap that has historically plagued rapid antigen tests [7]. This study, conducted with 103 upper respiratory tract swab samples, reported 95.1% sensitivity (for specimens with Ct ≤ 30) and 100% specificity when benchmarked against RT-qPCR, with no cross-reactivity to influenza A virus, respiratory syncytial virus, or rhinovirus [7]. Critically, mathematical modeling based on patient data revealed that the nanodiamond-based test could detect infection a mean of 2.0 days earlier than conventional gold nanoparticle-based lateral flow assays, and only 0.6 days after RT-qPCR [7]. This temporal advantage is clinically significant, as it directly impacts the potential for transmission risk reduction in both human and animal populations. The mechanism underlying this enhanced sensitivity lies in the nitrogen-vacancy centers within nanodiamonds, which exhibit spin-dependent fluorescence that can be modulated to eliminate background signal from complex clinical matrices-a particular advantage when testing samples with high mucoprotein content, such as bovine nasal secretions or avian cloacal swabs [7].

Electrochemical biosensors represent another nanotechnology platform that has demonstrated substantial clinical promise. A MXene/Pt/C nanocomposite-based electrochemical biosensor targeting the RdRp gene region of SARS-CoV-2 achieved a limit of detection of 0.4 attomolar (aM) using differential pulse voltammetry, with a correlation coefficient of 0.9977 across a dynamic range from 1 aM to 100 nM [28]. When validated against 192 clinical samples, this platform exhibited 100% accuracy and sensitivity, with 97.87% specificity and a limit of quantification of 60 copies/mL [28]. Importantly, the biosensor performed equivalently across multiple sample matrices-saliva, nasopharyngeal swabs, and serum-demonstrating the robustness required for veterinary applications where specimen type may vary by species and clinical presentation [28]. The MXene nanosheets (Ti₃C₂Tₓ) provide a high surface area for DNA probe immobilization, while the platinum-carbon composite amplifies the electrochemical signal upon hybridization with viral target sequences, enabling detection at concentrations orders of magnitude below those required for conventional antigen tests.

Nanomechanical cantilever-based biosensors offer yet another paradigm for viral antigen detection with exceptional sensitivity. A system developed for HIV-1 p24 antigen detection-a model applicable to numerous veterinary viral capsid proteins-achieved detection limits of 100 fg/mL in buffer and 1 pg/mL in human serum, with quantitative responses spanning several orders of magnitude [27]. The functionalization of microcantilevers with broadly cross-reactive monoclonal antibodies (ANT-152 and C65690M) enabled detection across diverse HIV-1 subtypes, a feature directly translatable to genetically variable veterinary viruses such as Foot-and-Mouth Disease Virus or Influenza A Virus in Cats. The nanomechanical transduction mechanism-whereby antigen binding induces surface stress changes that cause cantilever deflection-provides a label-free, real-time readout compatible with direct electronic output, making it suitable for integration into automated point-of-care systems [27]. For veterinary applications, this technology could be adapted to detect Canine Distemper Virus antigen in cerebrospinal fluid or Feline Leukemia Virus p27 antigen in whole blood, where early detection is critical for therapeutic intervention and infection control.

2.2 Analytical Performance Metrics: Sensitivity, Specificity, and Limit of Detection

The clinical utility of any diagnostic test hinges on its analytical performance characteristics, which must be rigorously evaluated against appropriate reference standards. For nanotechnology-driven viral tests, these metrics are influenced by multiple interdependent factors, including nanomaterial composition, probe design, signal transduction mechanism, sample preparation protocols, and the intrinsic biological properties of the target virus. A systematic meta-analysis of rapid antigen detection tests (RADTs) for SARS-CoV-2, encompassing 24 studies with 14,188 patients, reported a pooled sensitivity of 0.68 (95% CI: 0.59-0.76) and specificity of 0.99 (95% CI: 0.99-1.00), with a diagnostic odds ratio of 426.70 and a hierarchical summary receiver operating characteristic area of 0.98 [24]. This analysis revealed that sensitivity was significantly influenced by viral load, with pooled sensitivity increasing substantially for specimens with Ct values ≤ 25 or within 5 days of symptom onset [24]. These findings underscore a fundamental principle that applies across veterinary species: the performance of rapid diagnostic tests is inextricably linked to the kinetics of viral replication and shedding in the target host.

The correlation between viral load and test sensitivity has been well-documented for conventional lateral flow assays, but nanotechnology-enhanced platforms are designed to mitigate this limitation. A comparative evaluation of 122 CE-marked SARS-CoV-2 antigen rapid diagnostic tests in Germany revealed that sensitivity varied over a wide range, with 96 of 122 tests meeting the minimum threshold of 75% sensitivity for specimens with Cq ≤ 25 [35]. Notably, some tests demonstrated sensitivity as high as 97.5% for Cq < 30, indicating that optimization of nanomaterial-based signal amplification can substantially narrow the performance gap between rapid tests and RT-qPCR [35]. However, this study also identified 26 tests with unacceptably low sensitivity, including several that failed completely, highlighting the critical importance of independent, head-to-head evaluations before clinical deployment [35].

For veterinary applications, the performance of nanotechnology-driven tests must be evaluated across the diverse range of sample types encountered in clinical practice. A study evaluating two antigen rapid diagnostic tests (CerTest and Panbio) for SARS-CoV-2 demonstrated that sensitivity for samples with Ct ≤ 25 was 94.0% and 96.4%, respectively, but decreased dramatically to 14.0% and 24.4% for samples with Ct > 25 [36]. This pattern has profound implications for veterinary testing, where viral loads may vary significantly depending on the stage of infection, host immune status, and species-specific pathogenesis. For example, in outbreaks of Newcastle Disease Virus in poultry, viral shedding is highest in the first 3-5 days post-infection, necessitating diagnostic strategies that prioritize sampling during this window to maximize test sensitivity. Similarly, for chronic viral infections such as Bovine Leukemia Virus or Feline Immunodeficiency Virus, where proviral DNA integration precedes antibody production, nucleic acid-based nanotechnology platforms may offer superior diagnostic accuracy compared to antigen detection alone.

A particularly instructive example of nanotechnology-driven performance optimization is the feature-extracted surface-enhanced Raman spectroscopy (SERS) approach combined with machine learning classification. In a study utilizing gold nanoparticles on zirconia substrates (Au NPs/fZrO₂ and Au NPs/pZrO₂), SERS spectra from SARS-CoV-2 specimens were subjected to multiple preprocessing and normalization strategies, with support vector machine (SVM) classifiers trained using k-fold cross-validation [1]. Although z-score normalization combined with principal component analysis yielded the highest validation accuracy (>98%), the critical finding was that min-max normalization with manual peak selection demonstrated superior generalization, achieving blind test accuracies of 87.5% and 75% for the two substrate types [1]. Furthermore, artificial neural network-based deep learning models achieved optimal blind test accuracies of 93.75% for Au NPs/pZrO₂ and 87.50% for Au NPs/fZrO₂, demonstrating that the integration of advanced computational methods with nanomaterial-based detection can substantially enhance clinical performance [1]. This approach is directly translatable to veterinary diagnostics, where SERS fingerprinting could be developed for rapid identification of Avian Influenza Virus subtypes or differentiation of Pseudorabies Virus from other alphaherpesviruses causing neurological disease in swine.

2.3 Clinical Utility and Impact on Patient Management

The ultimate measure of any diagnostic test is its impact on clinical decision-making and patient outcomes. For nanotechnology-driven viral diagnostics, the evidence base for clinical utility is expanding, particularly in human medicine, but must be extrapolated cautiously to veterinary contexts. A systematic literature review examining the clinical impact of rapid molecular diagnostic tests for respiratory viruses found that these tests led to reductions in time to test results (range of reported medians: 0.2-3.8 hours versus 4.3-35.9 hours for standard molecular tests), with associated decreases in hospital length of stay, unnecessary antibiotic and antiviral prescribing, and hospital-acquired transmission [38]. The review also reported improvements in patient flow and reductions in exposure time for uninfected patients [38]. For veterinary practice, these outcomes translate directly to reduced antimicrobial use in food animal operations-a critical consideration given the global threat of antimicrobial resistance-and improved biosecurity through rapid identification and isolation of infected animals.

The potential for nanotechnology-driven tests to support antibiotic stewardship has been demonstrated in studies of host-response biomarkers. A rapid host-protein test for differentiating bacterial from viral infection, evaluated in emergency department and urgent care settings, showed diagnostic accuracy that could guide appropriate antibiotic prescribing [13]. While this test is not virus-specific, the concept of integrating host-response measurement with viral detection on nanotechnology platforms represents a promising avenue for veterinary applications. For example, in Porcine Epidemic Diarrhea Virus outbreaks, a test that simultaneously detects the virus and measures host inflammatory markers could distinguish between primary viral enteritis and secondary bacterial infections requiring antimicrobial therapy.

The clinical impact of rapid viral testing in pediatric populations has been specifically examined in European emergency departments, where a positive rapid viral test was associated with significantly less antibiotic prescribing (adjusted odds ratio 0.6, 95% CI: 0.5-0.8) [37]. Notably, 20% of positively tested children still received antibiotics, indicating that test results alone are insufficient to change prescribing behavior without accompanying clinical guidelines and education [37]. This finding is directly relevant to veterinary medicine, where rapid diagnostic tests for Bovine Respiratory Syncytial Virus or Canine Influenza A Virus could reduce unnecessary antimicrobial use in appropriate clinical contexts, but only if integrated into evidence-based treatment algorithms.

2.4 Operational Feasibility and Field Performance

The deployment of nanotechnology-driven viral tests in resource-limited settings-whether in low- and middle-income countries, remote wildlife field stations, or on-farm veterinary practices-requires careful consideration of operational factors including sample collection, test stability, user training, and result interpretation. A comprehensive evaluation of implementation requirements for COVID-19 rapid diagnostic tests in sub-Saharan Africa identified several critical challenges that apply equally to veterinary testing [22]. These include the need for validated finger-prick or non-invasive sampling methods, stability of test components at ambient temperatures (most tests are stored at ≤30°C), and the provision of adequate quality control materials [22]. The study noted that few antibody-based rapid diagnostic tests had been evaluated with capillary blood sampling at point of care, and none of the identified studies were conducted in sub-Saharan Africa, highlighting the gap between laboratory validation and field performance [22].

User experience studies have provided important insights into the real-world performance of self-administered lateral flow tests. A study of 264 participants using the AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay at home found that 96.6% completed the test with an overall average user experience score of 95.27% [34]. However, accuracy in interpreting test results was only 80.63%, with users scoring lower confidence when interpreting weak positive results [34]. This finding has significant implications for veterinary testing, particularly in situations where farmers or animal owners may be asked to perform on-farm testing. The design of tests must include clear visual indicators for positive, negative, and invalid results, with particular attention to the readability of weak positive signals that may occur during early infection or in samples with low viral loads.

The stability of nanotechnology-based tests under field conditions is a critical determinant of their operational feasibility. A dual-color latex microsphere-based lateral flow immunoassay for African Swine Fever Virus antibody detection demonstrated remarkable stability, with storage capability at 4°C for 16 months, room temperature (18-25°C) for 12 months, and 37°C for 10 months [5]. This thermal stability is essential for deployment in tropical regions where cold chain maintenance is challenging, and it compares favorably to many conventional ELISA kits that require continuous refrigeration. The assay also exhibited excellent repeatability, with intra- and inter-assay variability showing no significant differences, and achieved a detection sensitivity of 1:1024, comparable to commercial ELISA [5]. In a clinical evaluation of 159 samples, the kappa value of 0.955 indicated near-perfect agreement with the reference method, establishing the clinical validity of this nanotechnology-enhanced platform for ser

Comparative Analysis of Turn-off/on Fluorescent Sensors and SERS Platforms for SARS-CoV-2

The clinical diagnostic landscape for SARS-CoV-2 has evolved rapidly, driven by the imperative for rapid, sensitive, and deployable assays that transcend the limitations of centralized nucleic acid amplification testing (NAAT). Within the nanodiagnostic armamentarium, two distinct optical transduction modalities have garnered significant attention: fluorescence-based “turn-off/on” sensors, particularly those employing waste-derived carbon dots (CDs), and label-free Surface-Enhanced Raman Spectroscopy (SERS) platforms. While both exploit nanomaterial-analyte interactions to generate a detectable signal, their mechanisms of action, analytical performance metrics, operational complexity, and ultimate suitability for point-of-care (POC) applications diverge substantially. This comparative analysis, framed from a veterinary clinical pathology perspective, dissects these two platforms with reference to the specific exigencies of rapid viral diagnostic testing, drawing upon the substantial body of evidence from recent investigations [1, 2, 6, 14, 26, 29].

Mechanistic Foundations: Fluorescence Quenching vs. Plasmonic Enhancement

The turn-off/on fluorescent sensor, exemplified by the Fe³⁺-mediated carbon dot system described by Torre et al., operates on a principle of competitive binding and fluorescence modulation [2]. Here, waste-derived carbon dots (CDs) synthesized via a green hydrothermal route exhibit strong fluorescence (quantum yield of 35.9%). This fluorescence is efficiently quenched (“turned off”) upon the addition of Fe³⁺ ions, likely through a static quenching mechanism involving the formation of a non-fluorescent complex between the metal ion and surface functional groups on the CD. The subsequent introduction of the target SARS-CoV-2 ORF1ab oligonucleotide sequence restores fluorescence (“turned on”) because the viral nucleic acid, with its negatively charged phosphate backbone, possesses a higher affinity for Fe³⁺ than the CD surface, effectively sequestering the quencher from the fluorophore. This elegant “displacement” logic provides a direct, homogeneous assay format requiring no separation or washing steps.

In stark contrast, SERS is a vibrational spectroscopic technique that relies on the dramatic amplification of Raman scattering signals when analyte molecules are adsorbed onto or in close proximity to plasmonic nanostructures (commonly gold or silver nanoparticles) [1, 14, 29]. The electromagnetic enhancement mechanism, arising from the localized surface plasmon resonance (LSPR) of the nanostructured substrate, can amplify the inherently weak Raman signal by factors of 10⁶ to 10¹⁴, enabling single-molecule sensitivity under ideal conditions. For SARS-CoV-2 detection, label-free SERS exploits the unique spectral fingerprint of the viral particle itself-including contributions from the spike (S) protein, nucleocapsid (N) protein, and the lipid envelope-providing a multi-component signature that can be classified without the need for specific molecular recognition elements. This is fundamentally distinct from the fluorescence sensor, which requires a predetermined probe sequence for hybridization with a specific viral RNA target. SERS therefore offers a “spectral barcode” of the entire virion or its components, while the fluorescent sensor reports on the presence of a single, albeit conserved, genomic region [2].

Comparative Analytical Performance: Sensitivity, Selectivity, and Dynamic Range

A head-to-head comparison of analytical parameters reveals the relative strengths of each platform. The Fe³⁺@CD fluorescent sensor achieved a limit of detection (LOD) of 0.0092 µM (9.2 nM) for the ORF1ab target, with a linear dynamic range from 0.10 to 1.5 µM [2]. The system demonstrated excellent repeatability (RSD = 1.68%) and reproducibility (RSD = 3.61%), and critically, showed selectivity against non-target sequences, including those from SARS-CoV, underscoring its potential for specific nucleic acid detection. However, its detection limit, while respectable for a homogeneous fluorescence assay, is several orders of magnitude higher than the attomolar (aM) levels achieved by advanced electrochemical or SERS-based platforms. The SERS-based approaches, when coupled with robust machine learning (ML) and deep learning (DL) algorithms, have demonstrated the capacity to discriminate SARS-CoV-2 positive from negative specimens with clinical accuracies exceeding 93% in blind testing [1]. Tran et al., using Au NPs/fZrO₂ and Au NPs/pZrO₂ substrates, combined feature extraction with SVM and ANN classifiers, achieving blind test accuracies of up to 93.75% [1]. The analytical LOD of SERS for viral particles is typically in the range of 10² to 10⁴ viral copies/mL, approaching that of RT-qPCR and surpassing conventional rapid antigen tests (RDTs), which often fail below 10⁵ copies/mL [24, 40]. Furthermore, the SERS spectrum is information-rich, containing data on multiple viral components simultaneously. This allows for a “holistic” molecular fingerprint that can be analyzed via principal component analysis (PCA) and other dimensionality reduction techniques to not only detect presence but potentially identify viral variants based on subtle spectral changes in proteins like the spike glycoprotein [26].

A critical difference lies in the nature of the signal. The fluorescent sensor generates a specific, quantitative optical signal (fluorescence intensity) proportional to target concentration. Its dose-response is linear and straightforward [2]. SERS, while capable of quantitative analysis, is influenced by numerous variables, including the degree of nanoparticle aggregation, the orientation of the molecule on the surface, and the uniformity of the SERS substrate. Thus, achieving robust quantitation requires extensive preprocessing (cosmic spike removal, baseline correction, smoothing, normalization) and sophisticated multivariate statistical analysis [1]. The study by Tran et al. explicitly demonstrated that normalization strategy and feature extraction method profoundly impact classification accuracy, with z-score normalization combined with PCA yielding high validation accuracy, but min-max normalization with manual peak selection providing superior generalization on blind test sets [1]. This highlights the complexity of SERS data interpretation compared to the relatively simple fluorescence readout.

Operational and Clinical Considerations in a Veterinary Context

From a veterinary clinical pathology standpoint, the deployability of a diagnostic platform is as crucial as its analytical sensitivity. The Fe³⁺@CD turn-off/on sensor, as described, is a solution-phase assay requiring a fluorometer for readout [2]. The synthesis of CDs from waste biomass (sawdust) offers a low-cost, environmentally sustainable route to nanomaterials. However, the sensor’s performance is heavily contingent on pH (optimal at 7.4) and ionic strength, as matrix effects can influence Fe³⁺ binding and colloidal stability [2]. This necessitates careful sample preparation, typically requiring extraction of nucleic acids from complex matrices like nasal swabs or saliva, which adds time and resource burden. For field screening of livestock or wildlife populations-for instance, in outbreaks of [Avian Influenza Virus] in poultry or [African Swine Fever Virus] in swine-the need for pH-controlled buffers and a benchtop fluorometer may limit true POC utility.

SERS platforms, while more complex in data analysis, offer potential advantages in sample handling. Label-free SERS can, in principle, be performed directly on crude clinical samples, such as saliva or nasopharyngeal aspirate, without prior target amplification or extensive purification [1, 14]. The “fingerprint” nature of the SERS spectrum can differentiate between viral and host components, and even between different pathogens. This is particularly valuable for differential diagnosis of respiratory and systemic viral diseases in animals, where co-infections are common. For example, a single SERS assay could theoretically distinguish SARS-CoV-2 from other respiratory viruses like [Canine Influenza A Virus] or Equine Influenza A Virus, or from common bacterial pathogens, reducing the need for multi-target PCR panels. However, clinical SERS is not without its challenges. Substrate reproducibility remains a major industrial hurdle; the plasmonic properties of nanoparticles must be exquisitely controlled to ensure day-to-day and lab-to-lab reproducibility. Furthermore, the cost of fabricating high-performance SERS substrates (e.g., lithographically patterned nanostructures, core-shell nanoparticles) can be prohibitive for low-resource settings. The use of machine learning, while powerful, introduces a “black box” element that requires extensive training datasets and rigorous validation to avoid overfitting and ensure generalizability across different populations and viral variants [1, 26].

The spin-enhanced nanodiamond lateral flow test represents an intriguing quantum-sensing hybrid, bridging the gap between conventional gold nanoparticle LFIAs and advanced SERS [7]. This platform uses nitrogen-vacancy (NV) centers in nanodiamonds, where spin-dependent fluorescence can be modulated to reject background autofluorescence, a major limitation of standard fluorescence assays in complex clinical matrices. For SARS-CoV-2 antigen detection, this test demonstrated a clinical sensitivity of 95.1% (Ct ≤ 30) and 100% specificity in a study of 103 upper respiratory tract samples [7]. Significantly, modeling suggested the nanodiamond test could detect infection a mean of 2.0 days earlier than conventional gold nanoparticle LFIAs, and only 0.6 days after RT-qPCR [7]. This suggests that while simple fluorescence turn-off/on sensors offer elegance and low cost, quantum-enhanced approaches may provide the sensitivity needed to rival molecular methods for early-stage detection.

Suitability for Viral Variants and Future Outlook

A paramount concern for any rapid viral diagnostic is its resilience to genetic drift and shift in the target virus. The fluorescent sensor targets a specific oligonucleotide sequence within the ORF1ab gene [2]. While this region is relatively conserved, emergence of new variants with mutations in the probe-binding site could lead to false negatives. This problem has been well-documented for antigen-based RDTs, where mutations in the N protein of Alpha, Delta, and Omicron variants caused a 10-fold loss in detection sensitivity for some commercial assays [39]. In contrast, label-free SERS, by targeting the physical and chemical composition of the entire virion (lipids, proteins, glycans), is inherently less susceptible to point mutations in a single gene. The SERS spectrum represents a holistic fingerprint of the pathogen; major escape variants would require substantial changes in envelope composition to evade detection, making this platform inherently more “variant-proof” against emerging strains. This is a critical advantage for a platform intended for long-term surveillance of a rapidly evolving virus like SARS-CoV-2, and for adaptation to other veterinary viruses with high mutation rates, such as [Avian Influenza Virus] and [Porcine Reproductive and Respiratory Syndrome Virus].

In summary, the turn-off/on fluorescent sensor offers simplicity, low cost, and environmentally benign materials, making it an attractive candidate for screening in resource-limited settings, provided target amplification is performed. The SERS platform, while operationally and computationally more demanding, provides superior sensitivity, potentially single-virion detection capability, and an inherent robustness against sequence variation, positioning it as a powerful tool for confirmatory testing and variant surveillance. The choice between these platforms is not one of absolute superiority but of strategic deployment based on the clinical question, available resources, and acceptable trade-offs between speed, cost, and information depth.

Future Directions: Integration of Nanotechnology with Point-of-Care and Wearable Diagnostics

The trajectory of nanotechnology-enabled viral diagnostics is accelerating toward a convergence of three transformative domains: artificial intelligence (AI)-driven data interpretation, continuous physiological monitoring via wearable platforms, and multiplexed, multimodal nanoplatforms capable of real-time syndromic surveillance. As a veterinary clinical pathologist who has witnessed the devastating impacts of emerging viral pathogens across aquatic, avian, livestock, pet, and wildlife populations, I contend that the next decade will witness a paradigm shift from episodic, symptomatic testing to continuous, predictive health surveillance. This transition will be underpinned by the seamless integration of engineered nanomaterials with advanced computational algorithms, microfluidic architectures, and flexible electronic substrates.

The Convergence of Artificial Intelligence and Nanomaterial-Based Sensing

The most immediate and impactful direction lies in the synergistic coupling of machine learning (ML) and deep learning (DL) algorithms with nanomaterial-based transducers. Surface-enhanced Raman spectroscopy (SERS) platforms, which exploit plasmonic nanostructures to amplify molecular vibrational fingerprints, generate high-dimensional spectral data that are ideally suited for pattern recognition by artificial neural networks. Tran et al. [1] demonstrated that feature-extracted SERS data combined with support vector machine (SVM) classifiers and artificial neural networks achieved blind test accuracies exceeding 93% for SARS-CoV-2 classification, with the critical insight that normalization strategies and feature selection protocols profoundly influence generalization performance. This principle extends to any viral pathogen: the spectral signatures of Avian Influenza Virus hemagglutinin, Newcastle Disease Virus fusion protein, or Porcine Reproductive and Respiratory Syndrome Virus nucleocapsid can be distinguished with high fidelity provided the training datasets encompass sufficient strain diversity.

The SERA framework proposed by Pandey et al. [6] exemplifies a generalizable architecture: a SERS database spanning six analyte classes was used to train supervised learning models that predicted resonance shifts, intensity variations, and binding efficiencies with 92% accuracy, thereby accelerating sensor optimization without exhaustive empirical iteration. In the veterinary context, such frameworks could be trained on spectral libraries of Foot-and-Mouth Disease Virus, African Swine Fever Virus, and Classical Swine Fever Virus to enable instantaneous serotype discrimination at the point of sampling. Hülck [14] further articulated the concept of "Nanotechnology-based Analytics 4.0," wherein SERS and localized surface plasmon resonance (LSPR) sensors are integrated with ML algorithms for real-time monitoring of viral loads, achieving sensitivity comparable to reverse transcription polymerase chain reaction (RT-PCR) while eliminating the need for thermal cycling and nucleic acid extraction.

The integration of AI extends beyond spectral interpretation to encompass assay design itself. Martin et al. [32] employed molecular modeling and simulation-including Phyre2, RNAfold, RNAComposer, HADDOCK, and GROMACS-to predict the binding conformations of SELEX-derived DNA aptamers to Ebola virus nucleoprotein, with in silico rankings validated by microscale thermophoresis. This computational pre-screening approach dramatically reduces the experimental burden of aptamer selection by prioritizing candidates with favorable binding thermodynamics and steric complementarity. Such in silico pipelines are particularly valuable for emerging or high-consequence pathogens such as Nipah Virus in Pigs, Crimean-Congo Hemorrhagic Fever Virus in Animals, and Rift Valley Fever Virus, where rapid deployment of diagnostic reagents is paramount during outbreak scenarios.

Quantum-Enhanced and Spin-Based Diagnostic Modalities

A revolutionary frontier is the application of quantum biosensors-specifically nitrogen-vacancy (NV) centers in nanodiamonds-to viral antigen detection. DeCruz et al. [7] reported a clinical evaluation of a spin-enhanced nanodiamond lateral flow test for SARS-CoV-2 antigen, achieving 95.1% sensitivity (for cycle threshold ≤30) and 100% specificity across 103 clinical samples. The quantum mechanical principle underlying this platform is the ability to modulate the spin-dependent fluorescence of NV centers via microwave irradiation, thereby enabling background-free signal acquisition even in complex clinical matrices such as nasopharyngeal swabs and saliva. The mean detection time of 2.0 days earlier than conventional gold nanoparticle lateral flow assays represents a clinically meaningful advancement, particularly for interrupting transmission chains of highly contagious pathogens like Avian Influenza Virus and Swine Influenza A Virus in intensive production systems.

The implications for veterinary field diagnostics are profound. Quantum nanodiamond labels are photostable, chemically inert, and amenable to functionalization with a wide array of capture ligands, including monoclonal antibodies, nanobodies, and aptamers. Unlike gold nanoparticles, which suffer from plasmonic damping in turbid or highly scattering media, NV-center fluorescence can be read out using compact, low-cost optics compatible with handheld readers. This technology could be adapted for pen-side detection of White Spot Syndrome Virus in shrimp hemolymph, Koi Herpesvirus in carp mucus, or Canine Parvovirus in fecal specimens, where sample complexity has historically compromised the performance of conventional rapid tests.

Beyond lateral flow architectures, nanomechanical cantilever-based platforms represent another label-free, quantum-enabled modality. Samuel et al. [27] demonstrated that microcantilevers functionalized with broadly cross-reactive monoclonal antibodies could detect HIV-1 p24 antigen at concentrations as low as 100 fg/mL in buffer and 1 pg/mL in human serum, with quantification spanning several orders of magnitude. The detection principle-nanomechanical bending induced by antigen-antibody binding-is universal and can be multiplexed by arraying cantilevers with different capture ligands. For veterinary applications, such platforms could simultaneously screen for Bovine Viral Diarrhea Virus, Bovine Herpesvirus 1, and Bovine Respiratory Syncytial Virus from a single nasal swab, providing quantitative viral load data that informs both treatment decisions and biosecurity interventions.

Wearable and Continuous Monitoring Platforms

The transition from episodic point-of-care testing to continuous wearable diagnostics represents perhaps the most transformative direction in the field. Drawing inspiration from the extensive literature on non-enzymatic glucose biosensors for continuous glucose monitoring [42], researchers are now developing wearable nanosensors capable of real-time viral surveillance in interstitial fluid, sweat, saliva, and exhaled breath condensate. The electrochemical glucose sensor paradigm- wherein nanomaterials such as metallic nanoparticles, carbon nanotubes, graphene, and MXenes serve as transduction elements with high surface area and rapid electron transfer kinetics-provides a template for viral antigen and nucleic acid detection [45].

Bolourinezhad et al. [28] demonstrated an MXene/Pt/C nanocomposite-based electrochemical biosensor for SARS-CoV-2 RNA detection via DNA/RNA hybridization, achieving a limit of detection of 0.4 aM with 100% accuracy on clinical samples. The key advantage of MXene nanosheets (Ti₃C₂Tₓ) lies in their metallic conductivity, hydrophilic surface chemistry, and facile functionalization with capture probes, making them ideal candidates for integration into flexible, wearable substrates. When coupled with microfluidic sampling interfaces that continuously harvest sweat or interstitial fluid, such platforms could enable real-time monitoring of viral shedding patterns in high-risk populations-including poultry workers exposed to Avian Influenza Virus, swine farm personnel in contact with Swine Influenza A Virus, or veterinary staff treating companion animals infected with Canine Influenza A Virus or Feline Coronavirus and FIP.

Wearable platforms also offer unprecedented opportunities for monitoring host physiological responses to viral infection. The host-response blood test for discriminating bacterial from viral infections, validated by Iglesias-Ussel et al. [15] on the Biomeme Franklin platform, exemplifies how portable molecular diagnostics can measure host gene expression signatures to guide antimicrobial stewardship. Extending this concept to wearable formats, one can envision flexible microneedle arrays that sample interstitial fluid and interface with nanostructured electrochemical sensors to measure panels of host biomarkers-interferon-stimulated genes, chemokines, and acute-phase proteins-in real time. Such devices would be invaluable for early detection of emerging zoonotic threats such as Bat Coronaviruses or Hantaviruses in Rodents before they trigger widespread transmission.

The integration of reverse transcription loop-mediated isothermal amplification (RT-LAMP) with wearable or minimally invasive sampling interfaces is another active area of development. Quyen et al. [33] addressed the critical issue of carryover contamination in LAMP-based assays through the incorporation of Cod-uracil-DNA-glycosylase, achieving elimination of up to 2.29 × 10⁹ copies of contaminant amplicons per reaction while maintaining a limit of detection of 8 copies/reaction. This contamination-control strategy is essential for the deployment of wearable LAMP devices that may be reused or used in non-sterile field environments. The PATHPOD system developed by Nguyen et al. [9], which integrates RT-LAMP on a polymer cartridge with total internal reflection fluorescence readout, achieved clinical sensitivity and specificity comparable to RT-PCR in a 1.2 kg standalone device processing 12 samples in under 50 minutes. Scaling such architectures to wearable formats requires miniaturization of the heating elements, optical detection systems, and microfluidic valving, but recent advances in lab-on-printed circuit board (PCB) technology [8] suggest that the necessary electronics integration is achievable at negligible cost.

Multiplexed Nanoplatforms for Syndromic Surveillance

The clinical reality of viral infections-particularly in veterinary medicine-is that multiple pathogens often circulate simultaneously within a herd, flock, or population, producing overlapping clinical syndromes. The future of nanotechnology-enabled diagnostics must therefore embrace high-plex multiplexing capable of distinguishing among etiologically diverse agents from a single specimen. Chen et al. [5] developed a dual-color latex microsphere-based lateral flow immunoassay for African Swine Fever Virus antibody detection, using red latex microspheres conjugated to p72 antigen and blue latex microspheres conjugated to Chicken IgY as a dual-color reporting system. The assay achieved 1:1024 sensitivity with a Cohen's kappa of 0.955 against commercial ELISA, and the visual readout-a red control line for positive samples-enabled intuitive interpretation by field personnel.

Extending this concept to higher plexity, Wang et al. [17] developed a color-mixing encoding strategy for simultaneous detection of dengue and chikungunya IgM/IgG antibodies in human clinical samples within 30 minutes. The platform uniquely leveraged additive color mixing to generate distinct chromatic outputs for each analyte combination, enabling four-analyte discrimination with minimal instrumentation. For veterinary applications, analogous colorimetric encoding could be applied to the differential diagnosis of vesicular diseases in livestock-distinguishing Foot-and-Mouth Disease Virus, Swine Vesicular Disease Virus, Vesicular Stomatitis Indiana Virus, and Senecavirus A-a critical capability for outbreak response given the clinical indistinguishability of these pathogens.

The DNA tetrahedron-radiated nanonetwork (DTRN) developed by Cui et al. [4] represents a fundamentally different approach to multiplexing, wherein a tetrahedral DNA scaffold is used to spatially organize multiple rolling circle amplification (RCA) primers, enabling simultaneous detection of multiple enzymatic activities with exponential signal enhancement. The dual-mode (fluorescent and colorimetric) readout achieved detection limits as low as 5.76 × 10⁻⁴ U/mL for T4 polynucleotide kinase, with the orthogonal detection modalities providing internal cross-validation. In principle, the DTRN architecture can be programmed to detect any nucleic acid target by redesigning the recognition sequences, making it adaptable for multiplexed detection of Avian Influenza Virus subtypes, Infectious Bursal Disease Virus variants, or Porcine Circovirus 2 genotypes in a single reaction.

Lab-on-Chip and Microfluidic Nanosystems

The miniaturization of complex laboratory workflows onto microfluidic chips is a prerequisite for true point-of-care deployment in resource-limited settings. Sharma et al. [43] developed an automated RT-LAMP-based microfluidic chip that integrates RNA isolation, purification, and amplification on a single disposable device, enabling visual detection of SARS-CoV-2 from saliva or nasopharyngeal samples within 40 minutes. The chip architecture-designed for low-cost thermoplastic fabrication-is modular and can be adapted for other viral targets by substituting the primer sets. This is particularly relevant for aquatic animal health, where rapid, field-deployable diagnostics are urgently needed for pathogens such as Infectious Salmon Anemia Virus, Tilapia Lake Virus, and White Spot Syndrome Virus, which cause catastrophic economic losses in aquaculture systems with limited laboratory infrastructure.

The lab-on-PCB approach demonstrated by Muralidharan et al. [8] is particularly compelling from a scalability perspective. By leveraging the mature manufacturing infrastructure of the electronics industry, the authors fabricated disposable PCB-based chips for both isothermal amplification and electrochemical detection at near-zero cost. The heating and detection electronics were housed in a compact device costing less than $10, achieving a limit of detection of 10 copies/reaction for SARS-CoV-2 RNA. This manufacturing paradigm could be rapidly scaled to produce millions of chips for veterinary surveillance networks, enabling widespread screening for Avian Influenza Virus in wild bird populations or Porcine Epidemic Diarrhea Virus in swine production systems.

The integration of digital microfluidics (DMF) with enzyme-linked immunoassay (ELISA) protocols, as demonstrated by Knipes et al. [46] for measles and rubella serology in the Democratic Republic of the Congo, offers a blueprint for multiplexed serological testing in veterinary field settings. The DMF-ELISA platform achieved sensitivities and specificities of 82-89% compared to reference ELISA using droplet-based sample manipulation on an electrode array, eliminating the need for pipetting and reducing reagent consumption by orders of magnitude. For veterinary applications, DMF platforms could be configured to simultaneously measure IgG and IgM responses against multiple vaccine-preventable diseases-such as Canine Distemper Virus, Canine Parvovirus, and Canine Adenovirus-from a single drop of whole blood, enabling rapid assessment of vaccine efficacy in shelter or mobile clinic settings.

Emerging Biomarker Classes: Extracellular Vesicles and Cell-Free Nucleic Acids

Beyond direct detection of viral antigens and nucleic acids, nanotechnology platforms are increasingly being directed toward host-derived biomarkers that reflect the physiological state of infection. Extracellular vesicles (EVs)-nanoscale lipid bilayer particles secreted by all cells that carry molecular cargo mirroring the parent cell's state-represent a rich source of diagnostic information. Fan et al. [41] reviewed multidimensional EV analysis techniques encompassing physicochemical characterization, temporal profiling to capture dynamic secretion patterns, and spatial mapping within tissues and organs. For viral diagnostics, EVs shed from infected cells carry viral proteins, nucleic acids, and host response molecules that can be detected using nanoparticle-based biosensors with single-vesicle sensitivity.

Tiwari et al. [44] described how machine learning integration with EV analytics-including convolutional neural networks for imaging data, random forests for multi-omics integration, and graph neural networks for structural analysis-is accelerating the translation of EV-based diagnostics into clinical applications. In the veterinary context, circulating EVs could be captured using magnetic nanoparticles functionalized with antibodies against surface markers such as CD9, CD63, or CD81, followed by detection of EV-associated viral components using SERS or electrochemical readout. This approach would be particularly valuable for detecting infections caused by Feline Leukemia Virus, Equine Infectious Anemia Virus, or Bovine Leukemia Virus.

References

1. Tran N, Sitjar J, Tsai H, Chang C, Lee H, Wu X, et al.. Feature-extracted SERS combined with enhanced machine learning and deep learning for fast screening of COVID-19 inpatients . Talanta. 2026. DOI: https://doi.org/10.1016/j.talanta.2026.130000

2. Torre R, Esteves da Silva J, Pinto da Silva L. Turn-off/on fluorescent sensor for SARS-CoV-2 detection using waste-derived carbon dots. Sensors and Actuators B: Chemical. 2026. DOI: https://doi.org/10.1016/j.snb.2026.140009

3. Wu H, Li X, Liu Z, Song F, Cai R, Chen H, et al.. Advances in near-infrared fluorescence imaging for biomedicine . Coordination Chemistry Reviews. 2026. DOI: https://doi.org/10.1016/j.ccr.2026.217892

4. Cui W, Li M, Niu M, Wang R, Lv E, Qiao M, et al.. DNA tetrahedron-radiated nanonetwork for the dual-mode detection of FEN1 and T4 PNK activities . Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026. DOI: https://doi.org/10.1016/j.saa.2026.127759

5. Chen J, Shi Z, Ru Y, Li S, Zhu Y, Luo J, et al.. Rapid and visual dual-color lateral flow immunoassay for african swine fever virus antibody detection. Applied Microbiology and Biotechnology. 2026. DOI: https://doi.org/10.1007/s00253-025-13694-w

6. Pandey B, Sahaya M, Ponraj A, Kumarganesh S, Thiyaneswaran B, Rishabavarthani P, et al.. Enhanced plasmonic biosensors with machine learning for ultra-sensitive detection. Discover Nano. 2026. DOI: https://doi.org/10.1186/s11671-025-04422-4

7. DeCruz AT, Miller B, Huang D, McRobbie M, Donaldson F, McCoy LE, et al.. Quantum-enhanced nanodiamond rapid test advances early SARS-CoV-2 antigen detection in clinical diagnostics. Nature Communications. 2025. DOI: https://doi.org/10.1038/s41467-025-63066-1

8. Muralidharan ST, Hanze M, Ainla A, Möller B, Hamedi M, Toldrà A. Lab-on-PCB with integrated DNA amplification and electroanalytical detection for point-of-care diagnostics. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-12364-1

9. Nguyen T, Vinayaka AC, Huynh VN, Linh QT, Andreasen SZ, Golabi M, et al.. PATHPOD - A loop-mediated isothermal amplification (LAMP)-based point-of-care system for rapid clinical detection of SARS-CoV-2 in hospitals in Denmark. Sensors and actuators. B, Chemical. 2023. DOI: https://doi.org/10.1016/j.snb.2023.134085

10. Abasi M, Hasanzadeh E, Rafati A, Tamijani SMS, Rafaiee R, Golchin A. The role of advanced technologies against COVID-19: Prevention, Detection, and Treatments.. Current Stem Cell Research & Therapy. 2022. DOI: https://doi.org/10.2174/1574888x18666221221123505

11. Cherkaoui D, Heaney J, Huang D, Byott M, Miller B, Nastouli E, et al.. Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2. Diagnostics. 2022. DOI: https://doi.org/10.3390/diagnostics12051263

12. Lyberopoulou A, Efstathopoulos E, Gazouli M. Nanotechnology‐Based Rapid Diagnostic Tests. . 2016. DOI: https://doi.org/10.5772/63908

13. Bachur R, Kaplan SL, Arias CA, Ballard N, Carroll KC, Cruz A, et al.. A rapid host-protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy study. Journal of the American College of Emergency Physicians Open. 2024. DOI: https://doi.org/10.1002/emp2.13167

14. Hülck S. Nanotechnology-based analytics 4.0: an approach for real-time spectroscopic monitoring and rapid detection of SARS CoV-2. BiOS. 2024. DOI: https://doi.org/10.1117/12.3021766

15. Iglesias-Ussel MD, O’Grady N, Anderson J, Mitsis P, Burke TW, Henao R, et al.. A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform. Open Forum Infectious Diseases. 2024. DOI: https://doi.org/10.1093/ofid/ofae729

16. Williamson SF, Williams CJ, Lendrem BC, Wilson K. Sample size determination for point-of-care COVID-19 diagnostic tests: a Bayesian approach. Diagnostic and Prognostic Research. 2023. DOI: https://doi.org/10.1186/s41512-023-00153-1

17. Wang R, Ongagna-Yhombi SY, Lu Z, Centeno-Tablante E, Colt S, Cao X, et al.. Rapid Diagnostic Platform for Colorimetric Differential Detection of Dengue and Chikungunya Viral Infections. Analytical Chemistry. 2019. DOI: https://doi.org/10.1021/acs.analchem.9b00704

18. Hatem H, Mysara M, Ramadan R. Trends of nucleic acid - based point-of-care diagnostics for infectious diseases. Journal of Biological Engineering. 2026. DOI: https://doi.org/10.1186/s13036-026-00681-6

19. Esfandiari N, Arani AK, Jamshidi A, Miri O, Schwaminger S. Cell-free DNA in precision medicine: overcoming biological barriers through integrated nanoparticle platforms for simultaneous diagnosis and therapy. Journal of Nanobiotechnology. 2026. DOI: https://doi.org/10.1186/s12951-026-04220-9

20. Han G, Goncharov A, Eryilmaz M, Ye S, Palanisamy B, Ghosh R, et al.. Machine learning in point-of-care testing: innovations, challenges, and opportunities. Nature Communications. 2025. DOI: https://doi.org/10.1038/s41467-025-58527-6

21. Sadeghi P, Sohrabi H, Hejazi M, Jahanban-Esfahlan A, Baradaran B, Tohidast M, et al.. Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies. Trends in analytical chemistry : TRAC. 2021. DOI: https://doi.org/10.1016/j.trac.2021.116460

22. Jacobs J, Kühne V, Lunguya O, Affolabi D, Hardy L, Vandenberg O. Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review. Frontiers in Medicine. 2020. DOI: https://doi.org/10.3389/fmed.2020.557797

23. Zumla A, Al-Tawfiq J, Enne V, Kidd M, Drosten C, Breuer J, et al.. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Lancet. Infectious Diseases (Print). 2014. DOI: https://doi.org/10.1016/S1473-3099(14)70827-8

24. Lee J, Song J, Shim S. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis. Journal of Clinical Virology. 2021. DOI: https://doi.org/10.1016/j.jcv.2021.104985

25. Bachelet V. Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature.. Medwave. 2020. DOI: https://doi.org/10.5867/medwave.2020.03.7891

26. Garg P, Singhal G, Singhal SS. Next-generation viral detection through AI-enhanced nanotechnology: advances, challenges, and future directions. Frontiers in Molecular Biosciences. 2026. DOI: https://doi.org/10.3389/fmolb.2026.1750124

27. Samuel AG, Cornish D, Simons LM, Agarwal D, Shekhawat G, Hultquist J, et al.. Nanomechanical Systems for the rapid detection of HIV-1 p24 antigen. Biosensors & bioelectronics. 2025. DOI: https://doi.org/10.1016/j.bios.2025.117395

28. Bolourinezhad M, Rezayi M, Meshkat Z, Soleimanpour S, Mojarrad M, Zibadi F, et al.. Design of a rapid electrochemical biosensor based on MXene/Pt/C nanocomposite and DNA/RNA hybridization for the detection of COVID-19. Talanta: The International Journal of Pure and Applied Analytical Chemistry. 2023. DOI: https://doi.org/10.1016/j.talanta.2023.124804

29. Kim S, Lee J. Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis. BioChip Journal. 2022. DOI: https://doi.org/10.1007/s13206-022-00078-9

30. Hafiz M, Othman D, Muhammad MS, Puteh M, Kamal M, Halim A, et al.. Hydrothermal duck-feather keratin as a reagent-free bioreductant and capping matrix for bioactive silver nanoparticles. Discover Nano. 2026. DOI: https://doi.org/10.1186/s11671-026-04591-w

31. Santos-Silva S, López-López P, Perez-Jimenez AB, Freyre-Carrillo C, Fuentes A, Rivero-Juárez A, et al.. Development and clinical evaluation of a nanoparticle-based biosensor for rapid detection of Hepatitis E virus in human serum.. Analytica Chimica Acta. 2025. DOI: https://doi.org/10.1016/j.aca.2025.344758

32. Martin DR, Mutombwera AT, Madiehe A, Onani M, Meyer M, Cloete R. Molecular modeling and simulation studies of SELEX-derived high-affinity DNA aptamers to the Ebola virus nucleoprotein. Journal of Biomolecular Structure and Dynamics. 2024. DOI: https://doi.org/10.1080/07391102.2024.2302922

33. Quyen T, Vinayaka AC, Golabi M, Ngoc HV, Bang DD, Wolff A. Elimination of Carryover Contamination in Real-Time Reverse Transcriptase Loop-Mediated Isothermal Amplification for Rapid Detection of the SARS-CoV-2 Virus in Point-of-Care Testing. Frontiers in Cellular and Infection Microbiology. 2022. DOI: https://doi.org/10.3389/fcimb.2022.856553

34. Jing M, Bond R, Robertson L, Moore J, Kowalczyk AM, Price R, et al.. User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test. Scientific Reports. 2022. DOI: https://doi.org/10.1038/s41598-022-05097-y

35. Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman V, Drosten C, et al.. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2021. DOI: https://doi.org/10.2807/1560-7917.ES.2021.26.44.2100441

36. Pérez-García F, Romanyk J, Gómez-Herruz P, Arroyo T, Pérez-Tanoira R, Linares M, et al.. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. Journal of Clinical Virology. 2021. DOI: https://doi.org/10.1016/j.jcv.2021.104781

37. Tan CD, Hagedoorn N, Dewez JE, Borensztajn D, Both Uv, Carrol E, et al.. Rapid Viral Testing and Antibiotic Prescription in Febrile Children With Respiratory Symptoms Visiting Emergency Departments in Europe. The Pediatric Infectious Disease Journal. 2021. DOI: https://doi.org/10.1097/INF.0000000000003326

38. Mojebi A, Wu P, Keeping S, Hale B, Chase J, Beaubrun A. Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review. PLoS ONE. 2024. DOI: https://doi.org/10.1371/journal.pone.0303560

39. Raïch-Regué D, Muñoz-Basagoiti J, Perez-Zsolt D, Noguera-Julián M, Pradenas E, Riveira-Muñoz E, et al.. Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern. Frontiers in Microbiology. 2022. DOI: https://doi.org/10.3389/fmicb.2022.810576

40. Schuit E, Veldhuijzen I, Venekamp R, Bijllaardt Wvd, Pas S, Lodder E, et al.. Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. British medical journal. 2021. DOI: https://doi.org/10.1136/bmj.n1676

41. Fan Q, Xu Q, Gong Y, Niu Q, Yang C, Yang T, et al.. Multidimensional analysis of extracellular vesicles: From physicochemical to spatiotemporal dimensions . TrAC Trends in Analytical Chemistry. 2026. DOI: https://doi.org/10.1016/j.trac.2026.118914

42. He J, Chen B, Wang J, Wang Q. A brief description of electrochemical glucose biosensors and their future challenges. Nano Biomedicine and Engineering. 2026. DOI: https://doi.org/10.1016/j.nbe.2025.100020

43. Sharma S, Caputi M, Asghar W. Development of a Diagnostic Microfluidic Chip for SARS-CoV-2 Detection in Saliva and Nasopharyngeal Samples. Viruses. 2024. DOI: https://doi.org/10.3390/v16081190

44. Tiwari A, Widodo, Krisnawati DI, Tzou K, Kuo T. Machine learning for extracellular vesicles enables diagnostic and therapeutic nanobiotechnology. Journal of Nanobiotechnology. 2026. DOI: https://doi.org/10.1186/s12951-025-03952-4

45. Ganesh P, Elugoke SE, Lee S, Kim S, Ebenso E. Smart and emerging point of care electrochemical sensors based on nanomaterials for SARS-CoV-2 virus detection: Towards designing a future rapid diagnostic tool.. Chemosphere. 2024. DOI: https://doi.org/10.1016/j.chemosphere.2024.141269

46. Knipes A, Summers A, Sklavounos AA, Lamanna J, Campos RDd, Narahari T, et al.. Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo. PLoS ONE. 2022. DOI: https://doi.org/10.1371/journal.pone.0278749